Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
259K characters. Original on sec.gov ·
Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
TYSON FOODS, INC.
CONSOLIDATED STATEMENTS OF INCOME
(In millions, except per share data)
| Fiscal Year Ended | |||||||||||||||||
| October 3, 2026 | September 27, 2025 | September 28, 2024 | |||||||||||||||
| Sales | $ | 56,419 | $ | 54,441 | $ | 53,309 | |||||||||||
| Cost of Sales | 53,189 | 50,879 | 49,682 | ||||||||||||||
| Gross Profit | 3,230 | 3,562 | 3,627 | ||||||||||||||
| Selling, General and Administrative | 2,130 | 2,121 | 2,218 | ||||||||||||||
| Goodwill Impairment | — | 343 | — | ||||||||||||||
| Operating Income | 1,100 | 1,098 | 1,409 | ||||||||||||||
| Other (Income) Expense: | |||||||||||||||||
| Interest income | (37) | (73) | (89) | ||||||||||||||
| Interest expense | 406 | 449 | 481 | ||||||||||||||
| Other, net | 62 | (47) | (75) | ||||||||||||||
| Total Other (Income) Expense | 431 | 329 | 317 | ||||||||||||||
| Income before Income Taxes | 669 | 769 | 1,092 | ||||||||||||||
| Income Tax Expense | 196 | 262 | 270 | ||||||||||||||
| Net Income | 473 | 507 | 822 | ||||||||||||||
| Less: Net Income Attributable to Noncontrolling Interests | 20 | 33 | 22 | ||||||||||||||
| Net Income Attributable to Tyson | $ | 453 | $ | 474 | $ | 800 | |||||||||||
| Net Income Per Share Attributable to Tyson: | |||||||||||||||||
| Class A Basic | $ | 1.31 | $ | 1.37 | $ | 2.31 | |||||||||||
| Class B Basic | $ | 1.18 | $ | 1.22 | $ | 2.06 | |||||||||||
| Diluted | $ | 1.28 | $ | 1.33 | $ | 2.25 |
See accompanying Notes to Consolidated Financial Statements.
TYSON FOODS, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(In millions)
| Fiscal Year Ended | |||||||||||||||||
| October 3, 2026 | September 27, 2025 | September 28, 2024 | |||||||||||||||
| Net Income | $ | 473 | $ | 507 | $ | 822 | |||||||||||
| Other Comprehensive Income (Loss), Net of Taxes: | |||||||||||||||||
| Derivatives accounted for as cash flow hedges | 33 | (7) | (5) | ||||||||||||||
| Investments | (2) | — | 4 | ||||||||||||||
| Currency translation | 33 | (4) | 100 | ||||||||||||||
| Postretirement benefits | 10 | 4 | (9) | ||||||||||||||
| Total Other Comprehensive Income (Loss), Net of Taxes | 74 | (7) | 90 | ||||||||||||||
| Comprehensive Income | 547 | 500 | 912 | ||||||||||||||
| Less: Comprehensive Income Attributable to Noncontrolling Interests | 19 | 33 | 36 | ||||||||||||||
| Comprehensive Income Attributable to Tyson | $ | 528 | $ | 467 | $ | 876 |
See accompanying Notes to Consolidated Financial Statements.
TYSON FOODS, INC.
CONSOLIDATED BALANCE SHEETS
(In millions, except share and per share data)
| October 3, 2026 | September 27, 2025 | ||||||||||
| Assets | |||||||||||
| Current Assets: | |||||||||||
| Cash and cash equivalents | $ | 824 | $ | 1,229 | |||||||
| Accounts receivable, net | 2,365 | 2,524 | |||||||||
| Inventories | 5,578 | 5,681 | |||||||||
| Other current assets | 555 | 482 | |||||||||
| Total Current Assets | 9,322 | 9,916 | |||||||||
| Net Property, Plant and Equipment | 8,561 | 9,204 | |||||||||
| Goodwill | 9,469 | 9,469 | |||||||||
| Intangible Assets, net | 5,421 | 5,624 | |||||||||
| Other Assets | 2,333 | 2,445 | |||||||||
| Total Assets | $ | 35,106 | $ | 36,658 | |||||||
| Liabilities and Shareholders’ Equity | |||||||||||
| Current Liabilities: | |||||||||||
| Current debt | $ | 848 | $ | 909 | |||||||
| Accounts payable | 3,047 | 2,601 | |||||||||
| Other current liabilities | 2,337 | 2,879 | |||||||||
| Total Current Liabilities | 6,232 | 6,389 | |||||||||
| Long-Term Debt | 6,902 | 7,921 | |||||||||
| Deferred Income Taxes | 2,214 | 2,195 | |||||||||
| Other Liabilities | 2,039 | 1,926 | |||||||||
| Commitments and Contingencies (Note 20) | |||||||||||
| Shareholders’ Equity: | |||||||||||
| Common stock ($0.10 par value): | |||||||||||
| Class A-authorized 900 million shares, issued 378 million shares | 38 | 38 | |||||||||
| Convertible Class B-authorized 900 million shares, issued 70 million shares | 7 | 7 | |||||||||
| Capital in excess of par value | 4,770 | 4,686 | |||||||||
| Retained earnings | 18,394 | 18,647 | |||||||||
| Accumulated other comprehensive income (loss) | (116) | (191) | |||||||||
| Treasury stock, at cost – 101 million shares at October 3, 2026 and 95 million shares at September 27, 2025 | (5,479) | (5,102) | |||||||||
| Total Tyson Shareholders’ Equity | 17,614 | 18,085 | |||||||||
| Noncontrolling Interests | 105 | 142 | |||||||||
| Total Shareholders’ Equity | 17,719 | 18,227 | |||||||||
| Total Liabilities and Shareholders’ Equity | $ | 35,106 | $ | 36,658 |
See accompanying Notes to Consolidated Financial Statements.
TYSON FOODS, INC.
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
(In millions)
| Fiscal Year Ended | |||||||||||||||||||||||||||||||||||
| October 3, 2026 | September 27, 2025 | September 28, 2024 | |||||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | ||||||||||||||||||||||||||||||
| Class A Common Stock: | |||||||||||||||||||||||||||||||||||
| Balance at beginning and end of year | 378 | $ | 38 | 378 | $ | 38 | 378 | $ | 38 | ||||||||||||||||||||||||||
| Class B Common Stock: | |||||||||||||||||||||||||||||||||||
| Balance at beginning and end of year | 70 | 7 | 70 | 7 | 70 | 7 | |||||||||||||||||||||||||||||
| Capital in Excess of Par Value: | |||||||||||||||||||||||||||||||||||
| Balance at beginning of year | 4,686 | 4,597 | 4,560 | ||||||||||||||||||||||||||||||||
| Stock-based compensation and other | 84 | 89 | 37 | ||||||||||||||||||||||||||||||||
| Balance at end of year | 4,770 | 4,686 | 4,597 | ||||||||||||||||||||||||||||||||
| Retained Earnings: | |||||||||||||||||||||||||||||||||||
| Balance at beginning of year | 18,647 | 18,873 | 18,760 | ||||||||||||||||||||||||||||||||
| Net income attributable to Tyson | 453 | 474 | 800 | ||||||||||||||||||||||||||||||||
| Dividends | (706) | (700) | (687) | ||||||||||||||||||||||||||||||||
| Balance at end of year | 18,394 | 18,647 | 18,873 | ||||||||||||||||||||||||||||||||
| Accumulated Other Comprehensive Income (Loss), Net of Tax: | |||||||||||||||||||||||||||||||||||
| Balance at beginning of year | (191) | (184) | (260) | ||||||||||||||||||||||||||||||||
| Other comprehensive income (loss) attributable to Tyson | 75 | (7) | 76 | ||||||||||||||||||||||||||||||||
| Balance at end of year | (116) | (191) | (184) | ||||||||||||||||||||||||||||||||
| Treasury Stock: | |||||||||||||||||||||||||||||||||||
| Balance at beginning of year | 95 | (5,102) | 92 | (4,941) | 92 | (4,972) | |||||||||||||||||||||||||||||
| Purchase of Class A common stock | 8 | (427) | 4 | (196) | 1 | (49) | |||||||||||||||||||||||||||||
| Stock-based compensation | (2) | 50 | (1) | 35 | (1) | 80 | |||||||||||||||||||||||||||||
| Balance at end of year | 101 | (5,479) | 95 | (5,102) | 92 | (4,941) | |||||||||||||||||||||||||||||
| Total Shareholders’ Equity Attributable to Tyson | $ | 17,614 | $ | 18,085 | $ | 18,390 | |||||||||||||||||||||||||||||
| Equity Attributable to Noncontrolling Interests: | |||||||||||||||||||||||||||||||||||
| Balance at beginning of year | $ | 142 | $ | 124 | $ | 122 | |||||||||||||||||||||||||||||
| Net income attributable to noncontrolling interests | 20 | 33 | 22 | ||||||||||||||||||||||||||||||||
| Distributions to noncontrolling interest | (56) | (15) | (35) | ||||||||||||||||||||||||||||||||
| Business combinations | — | — | 1 | ||||||||||||||||||||||||||||||||
| Currency translation and other | (1) | — | 14 | ||||||||||||||||||||||||||||||||
| Total Equity Attributable to Noncontrolling Interests | $ | 105 | $ | 142 | $ | 124 | |||||||||||||||||||||||||||||
| Total Shareholders’ Equity | $ | 17,719 | $ | 18,227 | $ | 18,514 |
See accompanying Notes to Consolidated Financial Statements.
TYSON FOODS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In millions)
| Fiscal Year Ended | |||||||||||||||||
| October 3, 2026 | September 27, 2025 | September 28, 2024 | |||||||||||||||
| Cash Flows From Operating Activities: | |||||||||||||||||
| Net income | $ | 473 | $ | 507 | $ | 822 | |||||||||||
| Adjustments to reconcile net income to cash provided by operating activities: | |||||||||||||||||
| Depreciation | 1,167 | 1,093 | 1,159 | ||||||||||||||
| Amortization | 231 | 268 | 241 | ||||||||||||||
| Deferred income taxes | 3 | (76) | (45) | ||||||||||||||
| Gain on sale of storage facilities | — | (107) | — | ||||||||||||||
| Impairment of goodwill | — | 343 | — | ||||||||||||||
| Impairments and disposals of assets | 311 | 126 | 131 | ||||||||||||||
| Stock-based compensation expense | 110 | 100 | 101 | ||||||||||||||
| Other, net | 94 | 7 | (43) | ||||||||||||||
| (Increase) decrease in accounts receivable | 157 | (121) | 59 | ||||||||||||||
| (Increase) decrease in inventories | (62) | (449) | 153 | ||||||||||||||
| Increase (decrease) in accounts payable | 491 | 184 | (205) | ||||||||||||||
| Increase (decrease) in income taxes payable/receivable | (184) | 7 | 89 | ||||||||||||||
| Net changes in other operating assets and liabilities | (358) | 273 | 128 | ||||||||||||||
| Cash Provided by Operating Activities | 2,433 | 2,155 | 2,590 | ||||||||||||||
| Cash Flows From Investing Activities: | |||||||||||||||||
| Additions to property, plant and equipment | (770) | (978) | (1,132) | ||||||||||||||
| Purchases of marketable securities | (58) | (66) | (38) | ||||||||||||||
| Proceeds from sale of marketable securities | 85 | 62 | 35 | ||||||||||||||
| Proceeds from sale of storage facilities | 44 | 252 | — | ||||||||||||||
| Proceeds from sale of business | — | — | 174 | ||||||||||||||
| Proceeds from sale of equity investments | 84 | — | — | ||||||||||||||
| Acquisition of equity investments | — | (11) | (29) | ||||||||||||||
| Other, net | 73 | 76 | 102 | ||||||||||||||
| Cash Used for Investing Activities | (542) | (665) | (888) | ||||||||||||||
| Cash Flows From Financing Activities: | |||||||||||||||||
| Proceeds from issuance of debt | 1,597 | 175 | 2,415 | ||||||||||||||
| Payments on debt | (2,745) | (1,262) | (1,641) | ||||||||||||||
| Proceeds from issuance of commercial paper | 945 | — | 1,694 | ||||||||||||||
| Repayments of commercial paper | (945) | — | (2,285) | ||||||||||||||
| Purchases of Tyson Class A common stock | (414) | (196) | (49) | ||||||||||||||
| Dividends | (704) | (697) | (684) | ||||||||||||||
| Stock options exercised | 27 | 21 | 14 | ||||||||||||||
| Other, net | (69) | (18) | (45) | ||||||||||||||
| Cash Used for Financing Activities | (2,308) | (1,977) | (581) | ||||||||||||||
| Effect of Exchange Rate Change on Cash | 12 | (1) | 23 | ||||||||||||||
| (Decrease) Increase in Cash and Cash Equivalents | (405) | (488) | 1,144 | ||||||||||||||
| Cash and Cash Equivalents at Beginning of Year | 1,229 | 1,717 | 573 | ||||||||||||||
| Cash and Cash Equivalents at End of Year | $ | 824 | $ | 1,229 | $ | 1,717 |
See accompanying Notes to Consolidated Financial Statements.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
TYSON FOODS, INC.
NOTE 1: BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Description of Business
Tyson Foods, Inc. and its subsidiaries (collectively, the “Company,” “we,” “us,” “our,” “Tyson Foods” or “Tyson”) (NYSE: TSN) is a world-class food company and recognized leader in protein. Founded in 1935 by John W. Tyson, it has grown under four generations of family leadership. The Company is guided by its core values and unified by this purpose: Tyson Foods. We Feed the World Like Family™ and has a broad portfolio of iconic products and brands including Tyson®, Jimmy Dean®, Hillshire Farm®, Ball Park®, Wright®, State Fair®, aidells® and ibp®. Tyson Foods is dedicated to bringing high-quality food to every table in the world, safely and affordably, now and for future generations.
Consolidation
The consolidated financial statements include the accounts of all wholly owned subsidiaries, as well as majority-owned subsidiaries over which we exercise control and, when applicable, entities for which we have a controlling financial interest and variable interest entities for which we are the primary beneficiary. All significant intercompany accounts and transactions have been eliminated in consolidation.
Fiscal Year
We utilize a 52- or 53-week accounting period ending on the Saturday closest to September 30. The Company’s accounting cycle resulted in a 53-week year for fiscal 2026 and 52-week years for fiscal 2025 and fiscal 2024.
Recast of Certain Prior Period Information
Commencing in the first quarter of fiscal 2026, the Company no longer allocates corporate expenses and amortization to segments as these items are no longer used by our Chief Operating Decision Maker (“CODM”) in assessing the performance of, and allocating resources to, the segments. Accordingly, the Company revised its measure of segment profit to exclude corporate expenses and amortization and identified International as a reportable segment. Refer to Note 17: Segment Reporting for additional description of the segment changes. Prior periods have been recast to reflect the new presentation of segment operating income (loss) and International as a reportable segment. These changes primarily impacted Note 1: Business and Summary of Significant Accounting Policies, Note 3: Acquisitions and Dispositions, Note 5: Goodwill and Intangible Assets, Note 7: Restructuring and Related Charges, Note 13: Fair Value Measurements and Note 17: Segment Reporting. The recast of prior period information had no impact on our Consolidated Statements of Income, Consolidated Statements of Comprehensive Income, Consolidated Balance Sheets, Consolidated Statements of Shareholders’ Equity or Consolidated Statements of Cash Flows.
Cash and Cash Equivalents
Cash equivalents consist of investments in short-term, highly liquid securities having original maturities of three months or less, which are made as part of our cash management activity. The carrying values of these assets approximate their fair values. We primarily utilize a cash management system with a series of separate accounts consisting of lockbox accounts for receiving cash, concentration accounts to which funds are moved and several zero-balance disbursement accounts for funding payroll, accounts payable, livestock procurement, livestock grower payments and other disbursements. As a result of our cash management system, checks issued, but not presented to the banks for payment, may result in negative book cash balances. These negative book cash balances are included in accounts payable and other current liabilities. Checks outstanding in excess of related book cash balances totaled approximately $115 million and $100 million at October 3, 2026 and September 27, 2025, respectively.
Accounts Receivable
We record accounts receivable at net realizable value, which reflects an appropriate allowance for estimated credit losses. We estimate the allowance based on our historical write-offs, current and expected economic conditions, the level of past due accounts and the financial condition of our customers. At October 3, 2026 and September 27, 2025, our allowance for credit losses was $42 million and $49 million, respectively. We generally do not have collateral for our receivables, but we periodically evaluate the creditworthiness of our customers.
Inventories
Processed products, livestock and supplies and other are valued at the lower of cost or net realizable value. Cost includes purchased raw materials, live purchase costs, livestock growout costs (primarily feed, livestock grower pay and catch and haul costs), labor and manufacturing and production overhead, which are related to the purchase and production of inventories. At October 3, 2026, the cost of inventories was determined by either the first-in, first-out method or the weighted-average method, which is consistent with the methods used at September 27, 2025. Inventories are presented net of lower of cost or net realizable value adjustments of $227 million and $138 million as of October 3, 2026 and September 27, 2025, respectively. The following table reflects the major components of inventory as of October 3, 2026 and September 27, 2025 (in millions):
| 2026 | 2025 | ||||||||||
| Processed products | $ | 2,904 | $ | 3,086 | |||||||
| Livestock | 1,738 | 1,729 | |||||||||
| Supplies and other | 936 | 866 | |||||||||
| Total inventory | $ | 5,578 | $ | 5,681 |
Property, Plant and Equipment
Property, plant and equipment are stated at cost and generally depreciated using a straight-line method over the estimated lives for buildings and leasehold improvements of 10 to 33 years, machinery and equipment of 3 to 15 years and land improvements and other of 3 to 20 years. Major repairs and maintenance costs that significantly extend the useful life of the related assets are capitalized. Normal repairs and maintenance costs are charged to operations. We review the carrying value of long-lived assets for recoverability when events or changes in circumstances indicate that the carrying value may not be recoverable. Recoverability is assessed using undiscounted cash flows based on historical results and current projections of earnings before interest, taxes, depreciation and amortization. We measure impairment as the excess of carrying value over the fair value of an asset group. The fair value of an asset group is generally measured using discounted cash flows including market participant assumptions of future operating results and discount rates.
Goodwill and Intangible Assets
Definite life intangibles are initially recorded at fair value and amortized over the estimated period of benefit. Brands and trademarks are generally amortized using the straight-line method over 20 years or less. Customer relationships and supply arrangements are generally amortized over 7 to 30 years based on the pattern of revenue expected to be generated from the use of the asset. The gross cost and accumulated amortization of intangible assets are removed when the recorded amounts are fully amortized and the asset is no longer in use or the contract has expired. Amortization expense is generally recognized in selling, general and administrative expense. We review the carrying value of definite life intangibles at each balance sheet date if indications of impairment exist. Recoverability is assessed using undiscounted cash flows based on historical results and current projections of earnings before interest, taxes, depreciation and amortization. We measure impairment as the excess of carrying value over the fair value of the definite life intangible asset group. We use various valuation techniques to estimate fair value, with the primary techniques being relief-from-royalty and multi-period excess earnings valuation approaches, which use significant unobservable inputs, or Level 3 inputs, as defined by the fair value hierarchy. Under these valuation approaches, we are required to make estimates and assumptions about sales growth, operating margins, royalty rates and discount rates based on budgets, business plans, economic projections, anticipated future cash flows and marketplace data.
Goodwill represents the excess of the acquisition price over the fair value of the net assets acquired. Indefinite life intangible assets are initially recorded at fair value. Goodwill and indefinite life intangible assets are not amortized, but are reviewed for impairment at least annually or more frequently if impairment indicators arise. The first day of the fourth quarter is our annual impairment assessment date for goodwill and indefinite life intangible assets. However, we could be required to evaluate the recoverability of goodwill and indefinite life intangible assets outside of the required annual assessment if, among other things, we experience significant disruptions to the business, unexpected significant declines in operating results, divestiture of a significant component of the business, sustained decline in market capitalization or significant changes in macroeconomic factors such as increased interest and discount rates.
Our goodwill and indefinite life intangible assets are evaluated for impairment by first performing a qualitative assessment to determine whether a quantitative test is necessary. If it is determined, based on qualitative factors, the fair value of the reporting unit or indefinite life intangible asset may more likely than not be less than the carrying value, or if significant changes to macroeconomic factors have occurred that could materially impact fair value, a quantitative impairment test would be required. The quantitative test is to identify if an impairment exists by comparing the fair value of a reporting unit or indefinite life intangible asset with its carrying value. Additionally, we can elect to forgo the qualitative assessment and perform the quantitative test. If the carrying value of the reporting unit or indefinite life intangible asset exceeds the fair value, an impairment loss is recognized in an amount equal to that excess, not to exceed the carrying value of goodwill or the indefinite life intangible asset.
We estimate the fair value of our reporting units considering the use of various valuation techniques, with the primary technique being an income approach (discounted cash flow method), with another technique being a market approach (guideline public company method), which use significant unobservable inputs, or Level 3 inputs, as defined by the fair value hierarchy. We include assumptions about sales growth, operating margins, discount rates and valuation multiples which consider our budgets, business plans, economic projections, anticipated future cash flows and marketplace data, and are believed to reflect market participant views which would exist in an exit transaction. Assumptions are also made for varying perpetual growth rates for periods beyond the long-term business plan period. Generally, we utilize operating margin assumptions based on future expectations, operating margins historically realized in the reporting units’ industries and industry marketplace valuation multiples.
The fair value of our indefinite life intangible assets when performing a quantitative assessment is calculated principally using multi-period excess earnings and relief-from-royalty valuation approaches, which use significant unobservable inputs, or Level 3 inputs, as defined by the fair value hierarchy, and is believed to reflect market participant views which would exist in an exit transaction. Under these valuation approaches, we are required to make estimates and assumptions about sales growth, operating margins, royalty rates and discount rates based on budgets, business plans, economic projections, anticipated future cash flows and marketplace data. Assumptions are also made for varying perpetual growth rates for periods beyond the long-term business plan period.
Some of the inherent estimates and assumptions used in determining fair value of the reporting units and indefinite life intangible assets are outside the control of management, including interest rates, cost of capital, tax rates, market EBITDA comparables and credit ratings. While we believe we have made reasonable estimates and assumptions to calculate the fair value of the reporting units, it is possible a material change could occur. If our actual results are not consistent with our estimates and assumptions used to calculate fair value, it could result in material impairments of our goodwill or indefinite life intangible assets.
For fiscal 2026, we performed our annual goodwill and indefinite life impairment assessments as of the first day of our fourth quarter and elected to perform quantitative assessments for all of our material reporting units and indefinite life intangible assets. During fiscal 2026 and 2024, we determined that the fair values of all of our reporting units exceeded their carrying values. In fiscal 2025, our Beef reporting unit experienced lower than anticipated supply of market-ready cattle and an increased carrying value primarily associated with higher cattle costs and our forecasts indicated the timing of the recovery of market-ready cattle associated with the anticipated cattle herd rebuilding would be longer than previously estimated. Consequently, we determined the fair value of our Beef reporting unit was more likely than not less than the carrying value and performed a quantitative impairment assessment. Based on this assessment, we recognized a $343 million goodwill impairment charge to fully impair the remaining goodwill of the Beef reporting unit. During fiscal 2026, 2025 and 2024, we determined the fair values of our indefinite life intangible assets exceeded their carrying values.
We consider reporting units and indefinite life intangible assets with 20% or less excess fair value over carrying value to have a heightened risk of impairment. Although all our reporting units and indefinite life intangible assets had fair values that exceeded their respective carrying values by more than 20% as of our most recent assessment, they remain susceptible to impairments if assumptions, estimates or market conditions change significantly. Subsequent to our annual assessment, our market capitalization has fluctuated and at times has been near our book value, increasing the sensitivity of our goodwill impairment assessment to changes in our share price and other market conditions. Additionally, discount rates increased by approximately 50 basis points from the date of our annual impairment assessment. A sustained decline in our share price, particularly if accompanied by adverse changes in our operating results or assumptions, or a significant increase in discount rates, could result in a triggering event requiring an interim goodwill impairment assessment and potentially result in a material goodwill impairment charge.
Leases
We determine if an agreement is or contains a lease at its inception by evaluating if an identified asset exists that we control for a period of time. When a lease exists, we classify it as a finance or operating lease and record a right-of-use (“ROU”) asset and a corresponding lease liability at lease commencement. We have elected not to recognize ROU assets and lease liabilities for leases with a term of 12 months or less in our Consolidated Balance Sheets, and accordingly, lease expense for these short-term leases is recognized on a straight-line basis over the lease term. Finance lease ROU assets are presented within Net Property, Plant and Equipment, and finance lease liabilities are presented within Current debt and Long-Term Debt in our Consolidated Balance Sheets. Operating ROU assets are presented within Other Assets, and operating lease liabilities are recorded within Other current liabilities and Other Liabilities in our Consolidated Balance Sheets. Lease assets are subject to review for impairment within the related long-lived asset group.
ROU assets are initially measured based on the amount of the corresponding lease liabilities, adjusted for any prepayments, lease incentives received or initial direct costs incurred. The measurement of our ROU assets and liabilities includes all fixed payments and any variable payments based on an index or rate. Variable lease payments which do not depend on an index, or where rates are unknown, are excluded from lease payments in the measurement of the ROU asset and lease liability, and accordingly, are recognized as lease expense in the period the obligation for those payments is incurred. The present value of lease payments is based on our incremental borrowing rate according to the lease term and information available at the lease commencement date, as our lease arrangements generally do not provide an implicit interest rate. The incremental borrowing rate is derived using a hypothetically collateralized borrowing cost, based on our revolving credit facility, plus a country risk factor, where applicable. We consider our credit rating and the current economic environment in determining the collateralized rate.
Our lease arrangements can include fixed or variable non-lease components, such as common area maintenance, taxes and labor. We account for each lease and any non-lease components associated with that lease as a single lease component for all asset classes, except production and livestock grower asset classes embedded in service and supply agreements, and other asset classes that include significant maintenance or service components. We account for lease and non-lease components of an agreement separately based on relative stand-alone prices either observable or estimated if observable prices are not readily available. For asset classes where an election was made not to separate lease and non-lease components, all costs associated with a lease contract are disclosed as lease costs. The accounting for some of the Company’s leases may require significant judgment when determining whether a contract is or contains a lease, the lease term and the likelihood of exercising renewal or termination options. Our leases can include options to extend or terminate use of the underlying assets. These options are included in the lease term used to determine ROU assets and corresponding liabilities when we are reasonably certain we will exercise the option. Additionally, certain leases can have residual value guarantees, which are included within our lease liabilities when considered probable. Our lease agreements do not include significant restrictions or covenants.
Recognition, measurement and presentation of expenses and cash flows arising from a lease will depend on classification as a finance or operating lease. Operating lease expense is recognized on a straight-line basis over the lease term, whereas the amortization of finance lease assets is recognized on a straight-line basis over the shorter of the estimated useful life of the underlying asset or the lease term. Operating lease expense and finance lease amortization are presented in Cost of Sales or Selling, General and Administrative in our Consolidated Statements of Income depending on the nature of the leased item. Interest expense on finance lease obligations is recorded over the lease term and is presented in Interest expense, based on the effective interest method. All operating lease cash payments and interest payments on finance leases are presented within operating activities and all finance lease principal payments are presented within financing activities in our Consolidated Statements of Cash Flows.
Investments
We have investments in joint ventures and other entities. The equity method of accounting is used for entities in which we exercise significant influence but do not have a controlling interest or a variable interest in which we are the primary beneficiary. Under the equity method of accounting, the initial investment is recorded at cost and the investment is subsequently adjusted for our proportionate share of earnings or losses and distributions, including consideration of basis differences resulting from the difference between the initial carrying value of the investment and the underlying equity in net assets, as applicable. Equity method investments totaled $460 million and $566 million at October 3, 2026 and September 27, 2025, respectively.
Investments that are not accounted for under the equity method, do not have readily determinable fair values and do not qualify for the practical expedient to measure the investment using a net asset value per share, are recorded using the measurement alternative. Under this alternative, our equity interests are recorded at cost, less impairment, adjusted for observable price changes in orderly transactions for an identical or similar investment of the same issuer. At each reporting period, we assess these investments for impairment and whether they continue to qualify for the measurement alternative. If an investment is impaired, the investment is written down to its fair value, with the impairment recognized in earnings. Adjustments to the carrying value are recorded in Other, net in the Consolidated Statements of Income. Investments in joint ventures and other entities are reported in the Consolidated Balance Sheets in Other Assets.
We also have investments in marketable debt securities. We have determined all of our marketable debt securities are available-for-sale investments. These investments are reported at fair value based on quoted market prices as of the balance sheet date, with unrealized gains and losses, net of tax, recorded as a component of other comprehensive income.
The amortized cost of debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization, along with interest and dividends on securities classified as available for sale, is recorded in Interest income in the Consolidated Statements of Income. The cost of securities sold is based on the specific identification method. Realized gains and losses on the sale of debt securities and declines in value due to credit-related factors are recorded on a net basis in Other, net in the Consolidated Statements of Income.
Accrued Self-Insurance
We use a combination of insurance and self-insurance mechanisms to manage our exposure to health and welfare, workers’ compensation, auto liability and general liability risks. Liabilities associated with our retained risks are estimated, in part, by considering claims experience, demographic factors, severity factors and other actuarial assumptions.
Other Current Liabilities
Other current liabilities as of October 3, 2026 and September 27, 2025, include (in millions):
| 2026 | 2025 | ||||||||||
| Accrued salaries, wages and benefits | $ | 786 | $ | 909 | |||||||
| Taxes payable | 180 | 193 | |||||||||
| Accrued current legal contingencies | 439 | 712 | |||||||||
| Other | 932 | 1,065 | |||||||||
| Total other current liabilities | $ | 2,337 | $ | 2,879 | |||||||
Defined Benefit Plans
We recognize the funded status of defined pension and postretirement plans in the Consolidated Balance Sheets. The funded status is measured as the difference between the fair value of the plan assets and the benefit obligation. We measure our plan assets and liabilities at the end of our fiscal year. For a defined benefit pension plan, the benefit obligation is the projected benefit obligation; for any other defined benefit postretirement plan, such as a retiree healthcare plan, the benefit obligation is the accumulated postretirement benefit obligation. Any overfunded status is recognized as an asset and any underfunded status is recognized as a liability. Prior service cost (credit) and actuarial gains and losses that have not yet been recognized as components of net periodic benefit cost (credit) are recognized in Accumulated other comprehensive income (loss) and subsequently recognized as components of net periodic benefit cost (credit).
Derivative Financial Instruments
We purchase certain commodities, such as grains and livestock, during normal operations. As part of our commodity risk management activities, we use derivative financial instruments, primarily futures and options, to reduce our exposure to various market risks related to these purchases, as well as to changes in foreign currency exchange and interest rates. Contract terms of a financial instrument qualifying as a hedge instrument closely mirror those of the hedged item, providing a high degree of risk reduction and correlation. Contracts designated and highly effective at meeting risk reduction and correlation criteria are recorded using hedge accounting. If a derivative instrument qualifies and is designated as a hedge, depending on the nature of the hedge, changes in the fair value of the instrument either will be offset against the change in fair value of the hedged assets, liabilities or firm commitments through earnings, or recorded in Accumulated other comprehensive income (loss) in the Consolidated Balance Sheets and reclassified into earnings when the hedged forecasted transaction affects earnings. Instruments we hold as part of our risk management activities that do not meet the criteria for hedge accounting are measured at fair value with changes in fair value recognized in earnings. Changes in market value of derivatives used in our risk management activities relating to inputs of forward sales contracts, inventories on hand and anticipated purchases of inventories are recorded in Cost of Sales in the Consolidated Statements of Income. Changes in market value of derivatives used in our risk management activities related to interest rates are recorded in Interest expense in the Consolidated Statements of Income. Changes in the market value of derivatives used in our risk management activities related to foreign exchange contracts are recorded in Other, net in the Consolidated Statements of Income. We generally do not hedge anticipated transactions beyond 18 months.
Litigation Accruals
There are various legal proceedings pending or threatened against us. Accruals are recorded when it is probable a liability has been incurred and the amount of the liability can be reasonably estimated based on current law, progress of each case, opinions and views of legal counsel and other advisers, our experience in similar matters and intended response to the litigation. These amounts, which are not discounted and are exclusive of claims against third parties, are adjusted periodically as assessment efforts progress or additional information becomes available. We expense amounts for administering or litigating claims as incurred. Accruals for legal proceedings are included in Other current liabilities in the Consolidated Balance Sheets.
Supplier Financing Programs
We have supplier financing programs with financial institutions under which we agree to pay the financial institution the stated amount of confirmed invoices on the invoice due date for participating suppliers. Participation in these programs is optional and solely at the discretion of the supplier. Participating suppliers negotiate the terms of their arrangements directly with the financial institutions and may elect to receive early payment from the financial institutions. Supplier participation in these programs does not impact the amounts we owe or the payment terms with our suppliers. Payment terms with participating suppliers under these programs are generally up to 120 days.
We do not have an economic interest in a supplier’s participation in these programs or a direct financial relationship with the financial institutions funding the programs. Our obligations are limited to paying the participating financial institutions in accordance with the terms of the confirmed invoices. Outstanding payment obligations under these programs are included in Accounts payable in the Consolidated Balance Sheets. Amounts of supplier receivables financed by the financial institutions may be lower than amounts outstanding under our supplier financing programs because suppliers independently determine whether, and to what extent, to participate in the programs. Activity related to these programs is reflected within cash flows from operating activities in the Consolidated Statements of Cash Flows.
Changes in amounts outstanding under our supplier financing programs were as follows (in millions):
| October 3, 2026 | September 27, 2025 | |||||||||||||
| Confirmed obligations outstanding at the beginning of year | $ | 52 | $ | 45 | ||||||||||
| Invoices confirmed during the year | 852 | 288 | ||||||||||||
| Confirmed invoices paid during the year | (689) | (281) | ||||||||||||
| Confirmed obligations outstanding at the end of year | $ | 215 | $ | 52 |
Revenue Recognition
We recognize revenue primarily through retail, foodservice, international, industrial and other distribution channels. Our revenues primarily result from contracts with customers and are generally short term in nature with the delivery of product as the single performance obligation. We recognize revenue for the sale of the product at the point in time when our performance obligation has been satisfied and control of the product has transferred to our customer, which generally occurs upon shipment or delivery to a customer based on terms of the sale. We elected to account for shipping and handling activities that occur after the customer has obtained control of the product as a fulfillment cost rather than an additional promised service. Our contracts are generally less than one year, and therefore we recognize costs paid to third-party brokers to obtain contracts as expenses. Additionally, items that are not material in the context of the contract are recognized as expense. Any taxes collected on behalf of government authorities are excluded from net revenues.
Revenue is measured by the transaction price, which is defined as the amount of consideration we expect to receive in exchange for providing goods to customers. The transaction price is adjusted for estimates of known or expected variable consideration, which includes consumer incentives, trade promotions and allowances, such as coupons, discounts, rebates, volume-based incentives, cooperative advertising and other programs. Variable consideration related to these programs is recorded as a reduction to revenue based on amounts we expect to pay. We base these estimates on current performance, historical utilization and projected redemption rates of each program. We review and update these estimates regularly until the incentives or product returns are realized and the impact of any adjustments is recognized in the period the adjustments are identified. In many cases, key sales terms such as pricing and quantities ordered are established on a regular basis such that most customer arrangements and related incentives have a duration of less than one year. Amounts billed and due from customers are short term in nature and are classified as receivables since payments are unconditional and only the passage of time is required before payments are due. We generally do not provide customers with payment terms greater than one year. Freight expense associated with products shipped to customers is recognized in Cost of Sales in the Consolidated Statements of Income.
Advertising Expenses
Advertising expense is recognized in the period incurred within Selling, General and Administrative expense and totaled $297 million, $244 million and $267 million in fiscal 2026, 2025 and 2024, respectively.
Research and Development
Research and development costs are expensed as incurred and totaled $116 million, $126 million and $106 million in fiscal 2026, 2025 and 2024, respectively.
Business Combinations
We account for acquired businesses using the acquisition method of accounting, which requires that once control of a business is obtained, 100% of the assets acquired and liabilities assumed, including amounts attributable to noncontrolling interests, be recorded at the date of acquisition at their respective fair values. Any excess of the purchase price over the estimated fair values of the net assets acquired is recorded as goodwill. Acquisition-related expenses including transaction and integration costs are expensed as incurred.
We use various models to determine the value of assets acquired such as net realizable value to value inventory, cost method and market approach to value property, relief-from-royalty and multi-period excess earnings to value intangibles and discounted cash flow to value goodwill. We make estimates and assumptions about projected future cash flows including sales growth, operating margins, attrition rates and discount rates based on historical results, business plans, expected synergies, perceived risk and marketplace data considering the perspective of marketplace participants. Determining the useful life of an intangible asset also requires judgment as different types of intangible assets will have different useful lives and certain assets may be considered to have indefinite useful lives.
Government Assistance Programs
We periodically receive government assistance, typically in the form of cash grants or refundable tax credits. The programs generally specify conditions that must be met in order to earn the assistance, such as employment or employee retention targets and the construction or acquisition of property and equipment, and are often subject to specified time periods. If conditions are not satisfied or the applicable time period is not met, the assistance may be subject to reduction, repayment or termination.
To the extent amounts have been received by the Company in advance of satisfying the applicable conditions, they are recognized in Other current liabilities or Other Liabilities in the Consolidated Balance Sheets, as appropriate. Government assistance received during fiscal years 2026, 2025 and 2024 was not material to our consolidated financial statements.
Use of Estimates
The consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States, which require us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.
Recently Issued Accounting Pronouncements
In May 2026, the Financial Accounting Standards Board (the “FASB”) issued authoritative guidance to improve the accounting for and disclosure of environmental credits and environmental credit obligations. The guidance is effective for annual reporting periods beginning after December 15, 2027, which is our fiscal 2029, and interim reporting periods within those annual reporting periods. Amendments are required to be applied on a retrospective basis through a cumulative-effect adjustment to the opening balance of retained earnings at the date of initial application. Prior periods will not be recast. We are currently evaluating the impact this guidance will have on our consolidated financial statements and related disclosures.
In September 2025, the FASB issued authoritative guidance to modernize the accounting for internal-use software costs including the elimination of the stage-based capitalization model and updated disclosure requirements. The guidance is effective for annual reporting periods beginning after December 15, 2027, which is our fiscal 2029, and interim reporting periods within those annual reporting periods. Amendments may be applied using a prospective transition approach, a modified transition approach or a retrospective transition approach. We are currently evaluating the impact this guidance will have on our consolidated financial statements and related disclosures.
In November 2024, the FASB issued authoritative guidance to require the disclosure of certain additional expense information, including, among other items, purchases of inventory, employee compensation, depreciation and intangible asset amortization included within relevant Consolidated Statements of Income expense captions. The guidance is effective for annual reporting periods beginning after December 15, 2026, which is our fiscal 2028, and interim reporting periods within fiscal years beginning after December 15, 2027, which is our fiscal 2029. Amendments may be applied prospectively or retrospectively. We are currently evaluating the impact this guidance will have on the disclosures in our consolidated financial statements.
NOTE 2: CHANGES IN ACCOUNTING PRINCIPLES
In December 2023, the FASB issued authoritative guidance to enhance the transparency and decision usefulness of income tax disclosures primarily related to the rate reconciliation and income taxes paid information. The guidance is effective for annual reporting periods beginning after December 15, 2024, which is our fiscal 2026, and is required to be applied on a prospective basis with the option to apply retrospectively. We adopted this guidance on a prospective basis in fiscal 2026 and included the required disclosures in the notes to our annual consolidated financial statements.
In November 2025, the FASB issued guidance that clarifies certain aspects of hedge accounting and addresses several incremental hedge accounting issues arising from the global reference rate reform initiative. The guidance introduces improvements to more closely align hedge accounting with the economics of an entity’s risk management activities. The amendments are effective for annual reporting periods beginning after December 15, 2026, which is our fiscal 2028, and interim periods within those annual reporting periods. We early adopted the guidance on a prospective basis in fiscal 2026. The adoption did not have an impact on our consolidated financial statements.
NOTE 3: ACQUISITIONS AND DISPOSITIONS
Dispositions
In fiscal 2026, we completed the disposition of our 40% minority interest in a vertically integrated Brazilian poultry producer, which was accounted for under the equity method, for $120 million, consisting of $84 million of proceeds received at closing and $36 million of deferred consideration received in the first quarter of fiscal 2027. As a result of the transaction, we did not recognize a significant gain or loss in our Consolidated Statements of Income.
In the fourth quarter of fiscal 2024, we completed the sale of our Vienna, Georgia facility, which was included in our Chicken segment, for $174 million. As a result of the sale, we recognized a pretax gain of $16 million, which was reflected in Cost of Sales in our Consolidated Statements of Income in fiscal 2024. The facility’s carrying value of $158 million primarily consisted of fixed assets and inventory and included $63 million of goodwill that was not deductible for tax purposes. We concluded the sale of the facility was not a significant disposal or a strategic shift and, therefore, was not classified as a discontinued operation for any of the periods presented.
NOTE 4: PROPERTY, PLANT AND EQUIPMENT
The following table reflects major categories of property, plant and equipment and accumulated depreciation as of October 3, 2026 and September 27, 2025 (in millions):
| 2026 | 2025 | ||||||||||
| Land | $ | 213 | $ | 209 | |||||||
| Buildings and leasehold improvements | 7,192 | 7,079 | |||||||||
| Machinery and equipment | 12,318 | 12,015 | |||||||||
| Land improvements and other | 577 | 575 | |||||||||
| Buildings and equipment under construction | 359 | 509 | |||||||||
| 20,659 | 20,387 | ||||||||||
| Less accumulated depreciation | 12,098 | 11,183 | |||||||||
| Net Property, Plant and Equipment | $ | 8,561 | $ | 9,204 |
NOTE 5: GOODWILL AND INTANGIBLE ASSETS
The following table reflects goodwill activity for fiscal years 2026 and 2025 (in millions):
| Beef | Pork | Chicken | Prepared Foods | International | Consolidated | ||||||||||||||||||||||||||||||||||||
| Balance at September 28, 2024 (a) | $ | 343 | $ | 423 | $ | 3,001 | $ | 5,891 | $ | 161 | $ | 9,819 | |||||||||||||||||||||||||||||
| Fiscal 2025 Activity: | |||||||||||||||||||||||||||||||||||||||||
| Sale of business | — | — | — | — | (4) | (4) | |||||||||||||||||||||||||||||||||||
| Impairment losses | (343) | — | — | — | — | (343) | |||||||||||||||||||||||||||||||||||
| Currency translation | — | — | — | — | (3) | (3) | |||||||||||||||||||||||||||||||||||
| Balance at September 27, 2025 (a) | $ | — | $ | 423 | $ | 3,001 | $ | 5,891 | $ | 154 | $ | 9,469 | |||||||||||||||||||||||||||||
| Fiscal 2026 Activity | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
| Balance at October 3, 2026 (a) | $ | — | $ | 423 | $ | 3,001 | $ | 5,891 | $ | 154 | $ | 9,469 |
(a) Accumulated impairment losses included in goodwill for the Beef, Chicken and International segments were $1,236 million, $210 million and $295 million, respectively, at October 3, 2026 and September 27, 2025, compared with $893 million, $210 million and $295 million, respectively, at September 28, 2024.
The following table reflects intangible assets by type as of October 3, 2026 and September 27, 2025 (in millions):
| 2026 | 2025 | ||||||||||
| Amortizable intangible assets: | |||||||||||
| Brands and trademarks | $ | 992 | $ | 992 | |||||||
| Customer relationships | 2,389 | 2,385 | |||||||||
| Supply arrangements | 310 | 310 | |||||||||
| Patents, intellectual property and other | 45 | 45 | |||||||||
| Land use rights | 9 | 9 | |||||||||
| Total gross amortizable intangible assets | $ | 3,745 | $ | 3,741 | |||||||
| Less accumulated amortization | 2,402 | 2,195 | |||||||||
| Total net amortizable intangible assets | $ | 1,343 | $ | 1,546 | |||||||
| Brands and trademarks not subject to amortization | 4,078 | 4,078 | |||||||||
| Total intangible assets | $ | 5,421 | $ | 5,624 |
Amortization expense related to intangible assets was $207 million, $239 million and $229 million in fiscal 2026, 2025 and 2024, respectively. Estimated intangible asset amortization expense for the next five fiscal years is as follows: 2027 – $195 million; 2028 – $187 million; 2029 – $175 million; 2030 – $166 million; and 2031 – $131 million.
NOTE 6: LEASES
We lease certain equipment, buildings and land related to transportation, distribution, storage, production, livestock grower assets and office activities. These lease arrangements can be structured as a standard lease agreement or embedded within service or supply agreements. For further description of our lease accounting policy, refer to Note 1: Business and Summary of Significant Accounting Policies. Operating lease ROU assets and liabilities presented in our Consolidated Balance Sheets were as follows as of October 3, 2026 and September 27, 2025 (in millions):
| 2026 | 2025 | ||||||||||
| Other Assets | $ | 985 | $ | 887 | |||||||
| Other current liabilities | 196 | 201 | |||||||||
| Other Liabilities | 757 | 664 |
Finance lease ROU assets and liabilities presented in our Consolidated Balance Sheets were as follows as of October 3, 2026 and September 27, 2025 (in millions):
| 2026 | 2025 | ||||||||||
| Net Property, Plant and Equipment | $ | 161 | $ | 161 | |||||||
| Current debt | 59 | 55 | |||||||||
| Long-Term Debt | 109 | 113 |
The components of lease costs for fiscal years 2026, 2025 and 2024 were as follows (in millions):
| 2026 | 2025 | 2024 | |||||||||||||||
| Operating lease cost (a) | $ | 252 | $ | 232 | $ | 178 | |||||||||||
| Finance lease cost: | |||||||||||||||||
| Amortization of right-of-use assets | 58 | 50 | 36 | ||||||||||||||
| Interest on lease liabilities | 8 | 7 | 4 | ||||||||||||||
| Variable lease cost (b) | 571 | 545 | 527 | ||||||||||||||
| Short-term lease cost | 42 | 29 | 40 | ||||||||||||||
| Total | $ | 931 | $ | 863 | $ | 785 |
(a) Sublease income is immaterial and not deducted from operating lease cost.
(b) Variable lease costs are determined based on the volume of output received, flocks placed or other performance metrics.
Supplemental balance sheet information related to lease liabilities is as follows:
| Operating Leases | Finance Leases | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Weighted-average remaining lease term (in years) | 8 | 7 | 4 | 4 | |||||||||||||||||||
| Weighted-average discount rate | 5 | % | 5 | % | 5 | % | 5 | % |
Supplemental cash flow information related to lease liabilities is as follows (in millions):
| 2026 | 2025 | 2024 | |||||||||||||||
| Cash paid for amounts included in the measurement of lease liabilities: | |||||||||||||||||
| Operating cash outflows from operating leases | $ | 254 | $ | 231 | $ | 200 | |||||||||||
| Operating cash outflows from finance leases | $ | 8 | $ | 6 | $ | 4 | |||||||||||
| Financing cash outflows from finance leases | $ | 72 | $ | 77 | $ | 51 | |||||||||||
| ROU assets obtained in exchange for lease liabilities: | |||||||||||||||||
| Operating leases | $ | 324 | $ | 402 | $ | 360 | |||||||||||
| Finance leases | $ | 51 | $ | 117 | $ | 82 |
At October 3, 2026, future maturities of operating and finance lease liabilities were as follows (in millions):
| Operating Lease Commitments | Finance Lease Commitments | ||||||||||
| 2027 | $ | 234 | $ | 66 | |||||||
| 2028 | 190 | 49 | |||||||||
| 2029 | 155 | 30 | |||||||||
| 2030 | 125 | 17 | |||||||||
| 2031 | 102 | 8 | |||||||||
| 2032 and beyond | 345 | 15 | |||||||||
| Total undiscounted lease payments | $ | 1,151 | $ | 185 | |||||||
| Less: Imputed interest | 198 | 17 | |||||||||
| Present value of total lease liabilities | $ | 953 | $ | 168 |
At October 3, 2026, leases that had not yet commenced were not significant.
NOTE 7: RESTRUCTURING AND RELATED CHARGES
Network Optimization Plan
In fiscal 2025, the Company initiated a network optimization plan to optimize its global operations and logistics network. The disclosures below reflect actions approved through the end of fiscal 2026. The Company continues to strategically evaluate its operations and network and may approve additional actions in the future. We expect to incur costs related to the network optimization plan over a multi-year period and anticipate additional charges as further actions are approved. Significant changes to our strategies, outlook or intended use of assets may result in additional charges in future periods. The following table reflects the total estimated pretax expenses (income), including amounts recognized and expected to be recognized, for actions approved through October 3, 2026 (in millions):
| Beef | Pork | Chicken | Prepared Foods | International | Corporate Expenses | Other, net | Total | ||||||||||||||||||||||
| Severance and related costs | $ | 67 | $ | 1 | $ | 15 | $ | 16 | $ | 3 | $ | 6 | $ | — | $ | 108 | |||||||||||||
| Accelerated depreciation | 131 | — | 10 | 7 | — | — | — | 148 | |||||||||||||||||||||
| Asset write-offs | 223 | 21 | 33 | 34 | 12 | — | 8 | 331 | |||||||||||||||||||||
| Contract and lease terminations | 8 | — | 17 | 33 | — | — | 18 | 76 | |||||||||||||||||||||
| Gain on sale of assets | (23) | — | (40) | (72) | (1) | — | — | (136) | |||||||||||||||||||||
| Total | $ | 406 | $ | 22 | $ | 35 | $ | 18 | $ | 14 | $ | 6 | $ | 26 | $ | 527 |
Included in the above estimated pretax expenses (income) are $249 million of net charges that have resulted or will result in cash outflows and $414 million of non-cash charges, partially offset by $136 million of gains recognized from the sale of assets related to the network optimization plan.
During fiscal 2026, the Company increased the estimated pretax net charges by $441 million for additional actions approved under the network optimization plan. These actions included network changes in the Beef segment, consisting of the closure of two harvesting facilities, the transition of another harvesting facility to a single shift and the closure of a case-ready facility shared by the Beef and Pork segments. Additional actions included the closure of a production facility in the Prepared Foods segment, the sale of our minority interest in a joint venture and efforts to reduce support costs across all segments and corporate functions. The increase in estimated pretax net charges included $29 million of gains recognized from the sale of assets related to network changes.
We recognized net charges of $455 million related to the network optimization plan in fiscal 2026. These charges primarily consisted of $378 million related to facility closures in the Beef and Pork segments, net of a gain on sale of assets for the Beef network changes, and $29 million related to the facility closure in the Prepared Foods segment, with the remaining charges primarily related to support cost reductions and logistics network optimization activities. These charges included $172 million that have resulted or will result in cash outflows and $312 million of non-cash charges, partially offset by $29 million of gains recognized from the sale of assets related to the network optimization plan.
In fiscal 2025, we recognized net charges of $45 million related to the network optimization plan, which included a gain of $107 million from the sale of storage facilities. The charges primarily related to the closure of two facilities in the Prepared Foods segment, a non-harvesting facility closure in the Beef segment and asset write-offs in the Chicken, Prepared Foods and International segments, as well as severance and related costs and contract and lease termination costs. Additionally, in fiscal 2025, we executed various long-term cold storage service agreements and sold multiple Tyson-owned and operated storage facilities that primarily support our Chicken and Prepared Foods segments. As part of the sale agreements, we leased back the storage facilities for various periods ranging from approximately one to three years and entered into long-term cold storage service agreements associated with several fully automated cold storage facilities. We expect these actions will reduce network complexity, streamline inventory flow, simplify processes and reduce operating expenses.
The following table reflects pretax (income) expense related to the network optimization plan during fiscal 2026 (in millions):
| Beef | Pork | Chicken | Prepared Foods | International | Corporate Expenses | Total | ||||||||||||||||||||
| Cost of Sales: | ||||||||||||||||||||||||||
| Severance and related costs | $ | 60 | $ | — | $ | 3 | $ | 10 | $ | 1 | $ | — | $ | 74 | ||||||||||||
| Accelerated depreciation | 93 | — | 2 | 7 | — | — | 102 | |||||||||||||||||||
| Asset write-offs | 220 | 21 | — | — | — | — | 241 | |||||||||||||||||||
| Contract and lease terminations | 7 | — | 7 | 13 | — | — | 27 | |||||||||||||||||||
| Gain on sale of assets | (23) | — | (2) | (3) | (1) | — | (29) | |||||||||||||||||||
| Total Cost of Sales | $ | 357 | $ | 21 | $ | 10 | $ | 27 | $ | — | $ | — | $ | 415 | ||||||||||||
| Selling, General and Administrative: | ||||||||||||||||||||||||||
| Severance and related costs | 1 | 1 | 2 | 4 | — | 6 | 14 | |||||||||||||||||||
| Total Selling, General and Administrative | $ | 1 | $ | 1 | $ | 2 | $ | 4 | $ | — | $ | 6 | $ | 14 | ||||||||||||
| Other, net | 26 | |||||||||||||||||||||||||
| Total | $ | 358 | $ | 22 | $ | 12 | $ | 31 | $ | — | $ | 6 | $ | 455 |
The following table reflects pretax (income) expense related to the network optimization plan during fiscal 2025 (in millions):
| Beef | Pork | Chicken | Prepared Foods | International | Corporate Expenses | Total | ||||||||||||||||||||
| Cost of Sales: | ||||||||||||||||||||||||||
| Severance and related costs | $ | 6 | $ | — | $ | 8 | $ | 2 | $ | 2 | $ | — | $ | 18 | ||||||||||||
| Accelerated depreciation | 38 | — | 1 | — | — | — | 39 | |||||||||||||||||||
| Asset write-offs | 3 | — | 33 | 34 | 12 | — | 82 | |||||||||||||||||||
| Contract and lease terminations | 1 | — | 3 | 7 | — | — | 11 | |||||||||||||||||||
| Gain on sale of assets | — | — | (38) | (69) | — | — | (107) | |||||||||||||||||||
| Total Cost of Sales | $ | 48 | $ | — | $ | 7 | $ | (26) | $ | 14 | $ | — | $ | 43 | ||||||||||||
| Selling, General and Administrative: | ||||||||||||||||||||||||||
| Severance and related costs | — | — | 2 | — | — | — | 2 | |||||||||||||||||||
| Total Selling, General and Administrative | $ | — | $ | — | $ | 2 | $ | — | $ | — | $ | — | $ | 2 | ||||||||||||
| Total | $ | 48 | $ | — | $ | 9 | $ | (26) | $ | 14 | $ | — | $ | 45 |
The following table reflects our liability related to the network optimization plan during fiscal 2026 (in millions):
| Balance at September 27, 2025 | Expenses | Payments and Disposals | Balance at October 3, 2026 | |||||||||||
| Contract, lease and pension terminations | $ | 31 | $ | 79 | $ | (26) | $ | 84 | ||||||
| Severance and related costs | 3 | 88 | (58) | 33 | ||||||||||
| Total | $ | 34 | $ | 167 | $ | (84) | $ | 117 |
Executive Leadership Transition
During fiscal 2026, we announced certain executive leadership changes, including transitions involving our Chief Executive Officer and Chief Operating Officer, the appointment of their successors and the execution of a new employment agreement with the Chairman of our Board of Directors. In connection with these transitions, we recognized charges of $83 million during fiscal 2026, consisting of $42 million of severance and related charges and $41 million of other one-time cash payments. These charges were recognized as corporate expenses within Selling, General and Administrative expenses in our Consolidated Statements of Income.
2022 Program
The Company approved a restructuring program in fiscal 2022 (the “2022 Program”) to improve business performance, increase collaboration, enhance team member agility, enable faster decision-making and reduce redundancies. In conjunction with the 2022 Program, the Company relocated all corporate team members from its former Chicago, Downers Grove and Dakota Dunes-area corporate locations to its world headquarters in Springdale, Arkansas. The 2022 Program and related expenses were completed in fiscal 2024, and accordingly, disclosures for certain periods have been omitted because they were not material.
The following table reflects the pretax impact of the 2022 Program’s restructuring and related charges during fiscal 2024 (in millions):
| Beef | Pork | Chicken | Prepared Foods | International | Corporate Expenses | Total | |||||||||||||||||
| Severance costs | $ | — | $ | — | $ | — | $ | — | $ | — | $ | 4 | $ | 4 | |||||||||
| Relocation and related costs | 3 | 1 | — | 3 | — | 1 | 8 | ||||||||||||||||
| Contract and lease terminations | — | — | — | 19 | — | — | 19 | ||||||||||||||||
| Total | $ | 3 | $ | 1 | $ | — | $ | 22 | $ | — | $ | 5 | $ | 31 |
The above results included cash charges of $21 million and non-cash charges of $10 million, both of which were reflected in Selling, General and Administrative expenses in the Consolidated Statements of Income for fiscal 2024.
Plant Closures and Disposals
During fiscal 2023, to optimize asset utilization, the Company approved the closure of six processing facilities in the Chicken segment and, during fiscal 2024, approved the closure of two case-ready value-added plants in the Beef segment and a processing facility in the Pork segment. We ceased operations and shifted production to other facilities throughout fiscal 2023 and fiscal 2024.
During fiscal 2024, as a result of these plant closures and disposals, we recorded charges of $198 million primarily related to grower contract terminations, accelerated depreciation, severance, retention and related costs, as well as a pretax gain of $16 million related to the sale of a Chicken segment facility. During fiscal 2025, we recorded $23 million of additional charges related to contract termination costs, partially offset by $6 million of proceeds received related to a China plant relocation, collectively resulting in cash outflows. These charges, net of gains, are reflected in Cost of Sales in the Consolidated Statements of Income. Included in the fiscal 2024 results were $24 million of charges that have resulted or will result in cash outflows and $174 million of non-cash charges.
The following table reflects our liability related to plant closures during fiscal 2026 (in millions):
| Balance at September 27, 2025 | Plant Closure Charges | Payments | Balance at October 3, 2026 | |||||||||||
| Contract termination | $ | 72 | $ | — | $ | (20) | $ | 52 | ||||||
| Total | $ | 72 | $ | — | $ | (20) | $ | 52 |
Additionally, during fiscal 2024, we experienced a fire at a production facility in the Netherlands, which is included in the International segment, and subsequently approved the sale of the facility. For fiscal 2024, charges totaled $86 million, primarily related to property, plant and equipment impairments, severance costs, inventory write-offs and clean-up costs, partially offset by insurance proceeds. The net charges are reflected in Cost of Sales in the Consolidated Statements of Income and, for fiscal 2024, consisted of $31 million of charges that have resulted in cash outflows and $64 million of non-cash charges, partially offset by $9 million of insurance proceeds. In fiscal 2025, we recognized an additional $18 million of net insurance proceeds.
NOTE 8: DEBT
The following table reflects major components of debt as of October 3, 2026 and September 27, 2025 (in millions):
| 2026 | 2025 | ||||||||||
| Revolving credit facility | $ | — | $ | — | |||||||
| Revolving term loan credit facility | — | — | |||||||||
| Commercial paper | — | — | |||||||||
| Senior notes: | |||||||||||
| 4.00% Notes due March 2026 (“2026 Notes”) | — | 800 | |||||||||
| 3.55% Notes due June 2027 (“2027 Notes”) | 729 | 1,350 | |||||||||
| 7.00% Notes due January 2028 | 18 | 18 | |||||||||
| 4.35% Notes due March 2029 (“4.35% 2029 Notes”) | 765 | 1,000 | |||||||||
| 5.40% Notes due March 2029 (“5.40% 2029 Notes”) | 210 | 600 | |||||||||
| 5.10% Notes due August 2031 (“2031 Notes”) | 500 | — | |||||||||
| 6.13% Notes due November 2032 | 156 | 157 | |||||||||
| 5.70% Notes due March 2034 | 900 | 900 | |||||||||
| 4.88% Notes due August 2034 | 500 | 500 | |||||||||
| 4.95% Notes due February 2036 (“2036 Notes”) | 500 | — | |||||||||
| 5.60% Notes due January 2037 (“2037 Notes”) | 500 | — | |||||||||
| 5.15% Notes due August 2044 | 497 | 497 | |||||||||
| 4.55% Notes due June 2047 | 663 | 733 | |||||||||
| 5.10% Notes due September 2048 (“2048 Notes”) | 1,485 | 1,490 | |||||||||
| Discount on senior notes | (34) | (34) | |||||||||
| Term loan facility due May 2028 | — | 440 | |||||||||
| Finance leases | 168 | 168 | |||||||||
| Other | 237 | 251 | |||||||||
| Unamortized debt issuance costs | (44) | (40) | |||||||||
| Total debt | 7,750 | 8,830 | |||||||||
| Less current debt | 848 | 909 | |||||||||
| Total long-term debt | $ | 6,902 | $ | 7,921 |
Annual maturities of debt for the next five fiscal years are as follows: 2027 – $848 million; 2028 – $74 million; 2029 – $1,014 million; 2030 – $28 million; and 2031 – $521 million.
Revolving Credit Facility and Letters of Credit
We have a $2.5 billion revolving credit facility that supports short-term funding needs and serves as a backstop to our commercial paper program. The facility will mature and the commitments thereunder will terminate in April 2030 with options for two one-year extensions. Under the terms of the revolving credit facility, we have the option to establish incremental commitment increases of up to an aggregate amount of $500 million if certain conditions are met. At October 3, 2026, amounts available for borrowing under this facility totaled $2.5 billion before deducting amounts to backstop our commercial paper program. At October 3, 2026, we had no outstanding borrowings and no outstanding letters of credit issued under this facility. At October 3, 2026, we had $82 million of bilateral letters of credit issued separately from the revolving credit facility, none of which were drawn upon. Our letters of credit are issued primarily in support of workers’ compensation insurance programs and other legal obligations. In the future, if any of our subsidiaries guarantee any of our material indebtedness, such subsidiary would also be required to guarantee the indebtedness, obligations and liabilities under this facility.
Revolving Term Loan Credit FacilityIn December 2025, we entered into a $750 million revolving term loan credit facility. The facility will mature and commitments thereunder will terminate in December 2028. Prior to maturity, we may elect to convert all or part of the outstanding borrowings into one or more term loans that will mature up to seven years after the facility’s maturity date. Interest on borrowings under the facility is based either on term or daily simple secured overnight financing rates, with an applicable spread, or an alternative base rate with an applicable spread. The facility contains covenants and other terms that are generally consistent with those of our revolving credit facility. At October 3, 2026, we had no outstanding borrowings under this facility and amounts available for borrowing under this facility totaled $750 million. Concurrent with the entry into the revolving term loan credit facility, we repaid the $440 million outstanding borrowing under a term loan facility due May 2028 using cash on hand and terminated the facility.
2036 Notes
In February 2026, we issued $500 million aggregate principal amount of senior unsecured notes due February 2036. The net proceeds, together with cash on hand, were used to retire the 2026 Notes. Interest on the 2036 Notes is payable semi-annually in February and August. After deducting an original issue discount of $2 million, we received net proceeds of $498 million and incurred debt issuance costs of $5 million in connection with the issuance.
2031 and 2037 Notes
In August 2026, we issued $1.0 billion aggregate principal amount of senior unsecured notes, consisting of $500 million due August 2031 and $500 million due January 2037. Interest on the 2031 Notes is payable semi-annually in February and August, and interest on the 2037 Notes is payable semi-annually in January and July. After deducting original issue discounts totaling $2 million, we received net proceeds of $998 million and incurred debt issuance costs of $9 million in connection with the issuance.
Concurrently with the issuance, we commenced tender offers to purchase certain outstanding senior notes and subsequently repurchased $571 million aggregate principal amount of our 2027 Notes, $235 million aggregate principal amount of our 4.35% 2029 Notes and $390 million aggregate principal amount of our 5.40% 2029 Notes. We used the net proceeds from the issuance of the 2031 and 2037 Notes, together with cash on hand, to fund the repurchases. The repurchases did not result in a significant net gain or loss on extinguishment of debt.
Commercial Paper Program
We have a commercial paper program under which we may issue unsecured short-term promissory notes up to an aggregate maximum principal amount of $1.75 billion. As of October 3, 2026, we had no commercial paper outstanding. Our ability to access commercial paper in the future may be limited or its costs increased.
Senior Note Repayments
During fiscal 2026 and 2025, we repurchased $125 million and $30 million, respectively, of senior notes through open-market purchases.
Debt Covenants
Our revolving credit and revolving term loan credit facilities contain affirmative and negative covenants that, among other things, may limit or restrict our ability to: create liens and encumbrances; incur debt; merge, dissolve, liquidate or consolidate; make acquisitions and investments; dispose of or transfer assets; change the nature of our business; engage in certain transactions with affiliates; and enter into hedging transactions, in each case, subject to certain qualifications and exceptions. In addition, we are required to maintain a minimum interest expense coverage ratio.
Our senior notes also contain affirmative and negative covenants that, among other things, may limit or restrict our ability to: create liens; engage in certain sale/leaseback transactions; and engage in certain consolidations, mergers and sales of assets.
We were in compliance with all debt covenants at October 3, 2026.
NOTE 9: EQUITY
Capital Stock
We have two classes of capital stock, Class A Common Stock, $0.10 par value (“Class A stock”) and Class B Common Stock, $0.10 par value (“Class B stock”). Holders of Class B stock may convert such stock into Class A stock on a share-for-share basis. Holders of Class B stock are entitled to 10 votes per share, while holders of Class A stock are entitled to one vote per share on matters submitted to shareholders for approval. As of October 3, 2026, Tyson Limited Partnership (the “TLP”) owned 99.987% of the outstanding shares of Class B stock and the TLP and members of the Tyson family owned, in the aggregate, 2.52% of the outstanding shares of Class A stock, giving them, collectively, control of approximately 72.40% of the total voting power of the outstanding voting stock.
The Class B stock is considered a participating security requiring the use of the two-class method for the computation of basic earnings per share. The two-class computation method for each period reflects the cash dividends paid for each class of stock, plus the amount of allocated undistributed earnings (losses) computed using the participation percentage, which reflects the dividend rights of each class of stock. Basic earnings per share were computed using the two-class method for all periods presented. The shares of Class B stock are considered to be participating convertible securities since the shares of Class B stock are convertible on a share-for-share basis into shares of Class A stock. Diluted earnings per share, if dilutive, were computed assuming the conversion of the Class B shares into Class A shares as of the beginning of each period.
Dividends
Cash dividends cannot be paid to holders of Class B stock unless they are simultaneously paid to holders of Class A stock. The per share amount of the cash dividend paid to holders of Class B stock cannot exceed 90% of the cash dividend simultaneously paid to holders of Class A stock. We pay quarterly cash dividends to Class A and Class B shareholders. We paid Class A dividends per share of $2.04, $2.00 and $1.96 in fiscal 2026, 2025 and 2024, respectively. We paid Class B dividends per share of $1.84, $1.80 and $1.76 in fiscal 2026, 2025 and 2024, respectively. Effective November 13, 2026, the Board of Directors increased the quarterly dividend previously declared on August 6, 2026, to $0.52 per share on our Class A stock and $0.468 per share on our Class B stock. The increased quarterly dividend is payable on December 15, 2026, to shareholders of record at the close of business on December 1, 2026. We had dividends payable of $175 million and $174 million at October 3, 2026 and September 27, 2025, respectively.
Share Repurchases
As of October 3, 2026, 39.8 million shares remained available for repurchase under the Company’s share repurchase program. The program has no fixed or scheduled termination date, and the timing and extent to which we repurchase shares will depend upon, among other things, our working capital needs, markets, industry conditions, liquidity targets, limitations under our debt obligations and regulatory requirements. In addition to the share repurchase program, we repurchase shares to fund certain obligations under our equity compensation plans.
A summary of cumulative share repurchases of our Class A stock for fiscal years 2026, 2025 and 2024 is as follows (in millions):
| October 3, 2026 | September 27, 2025 | September 28, 2024 | ||||||||||||||||||||||||||||||||||||
| Shares | Dollars | Shares | Dollars | Shares | Dollars | |||||||||||||||||||||||||||||||||
| Shares repurchased: | ||||||||||||||||||||||||||||||||||||||
| Under share repurchase program | 7.4 | $ | 408 | 3.1 | $ | 174 | — | $ | — | |||||||||||||||||||||||||||||
| To fund certain obligations under equity compensation plans | 0.4 | 19 | 0.4 | 22 | 0.9 | 49 | ||||||||||||||||||||||||||||||||
| Total share repurchases | 7.8 | $ | 427 | 3.5 | $ | 196 | 0.9 | $ | 49 |
The above share repurchases under the share repurchase program for fiscal 2026 included $13 million of shares repurchased for which cash settlement had not occurred as of fiscal year end.
NOTE 10: INCOME TAXES
Income before Income Taxes for fiscal years 2026, 2025 and 2024 consisted of the following (in millions):
| 2026 | 2025 | 2024 | |||||||||||||||
| United States | $ | 264 | $ | 278 | $ | 864 | |||||||||||
| Foreign | 405 | 491 | 228 | ||||||||||||||
| Total | $ | 669 | $ | 769 | $ | 1,092 |
Income Tax Expense for fiscal years 2026, 2025 and 2024 consisted of the following (in millions):
| 2026 | 2025 | 2024 | |||||||||||||||
| Federal | $ | 89 | $ | 124 | $ | 188 | |||||||||||
| State and local | 5 | 54 | 34 | ||||||||||||||
| Foreign | 102 | 84 | 48 | ||||||||||||||
| Total | $ | 196 | $ | 262 | $ | 270 | |||||||||||
| Current | $ | 193 | $ | 338 | $ | 315 | |||||||||||
| Deferred | 3 | (76) | (45) | ||||||||||||||
| Total | $ | 196 | $ | 262 | $ | 270 |
Income taxes paid, net of refunds, for fiscal year 2026, consisted of the following (in millions):
| 2026 | |||||
| Federal | $ | 148 | |||
| State and local: | |||||
| New York | 77 | ||||
| Other | 61 | ||||
| Foreign: | |||||
| Brazil | 37 | ||||
| Other | 54 | ||||
| Total | $ | 377 |
Income taxes paid, net of refunds, for fiscal years 2025 and 2024 are presented in Note 18: Supplemental Cash Flow Information.
The following table reconciles the statutory federal income tax rate to our effective income tax rate for fiscal year 2026:
| 2026 | |||||||||||
| Amount | Rate | ||||||||||
| Federal statutory rate | $ | 141 | 21.0 | % | |||||||
| State and local income taxes, net of federal income tax effect (a) | 27 | 4.1 | % | ||||||||
| Foreign tax effects: | |||||||||||
| Brazil: | |||||||||||
| Statutory rate differential | 21 | 3.1 | % | ||||||||
| Other | (3) | (0.4) | % | ||||||||
| China: | |||||||||||
| Tax exempt income | (8) | (1.3) | % | ||||||||
| Withholding taxes | 10 | 1.5 | % | ||||||||
| Other | (1) | (0.1) | % | ||||||||
| Other foreign jurisdictions | (2) | (0.3) | % | ||||||||
| Effect of cross-border tax laws | 6 | 0.9 | % | ||||||||
| Tax credits: | |||||||||||
| Research and development tax credits | (15) | (2.2) | % | ||||||||
| Other | (11) | (1.7) | % | ||||||||
| Changes in valuation allowances | 8 | 1.2 | % | ||||||||
| Nontaxable or nondeductible items: | |||||||||||
| Company-owned life insurance | (11) | (1.6) | % | ||||||||
| Officer compensation expense | 33 | 4.9 | % | ||||||||
| Other | 4 | 0.6 | % | ||||||||
| Changes in unrecognized tax benefits | (1) | (0.2) | % | ||||||||
| Other | (2) | (0.2) | % | ||||||||
| Total Income Tax Expense and effective tax rate | $ | 196 | 29.3 | % |
(a) State taxes in California, Pennsylvania, Texas and Georgia comprised the majority of the tax effect in this category.
The following table reconciles the statutory federal income tax rate to our effective income tax rate for fiscal years 2025 and 2024:
| 2025 | 2024 | |||||||||||||
| Federal income tax rate | 21.0 | % | 21.0 | % | ||||||||||
| State income taxes | 4.7 | 3.4 | ||||||||||||
| Unrecognized tax benefits, net | 1.2 | 0.7 | ||||||||||||
| General business credits | (2.1) | (1.9) | ||||||||||||
| Company-owned life insurance | (1.3) | (1.7) | ||||||||||||
| Officer compensation expense | 1.9 | 1.1 | ||||||||||||
| Foreign rate differences and valuation allowances | (1.8) | 0.3 | ||||||||||||
| Goodwill | 9.4 | 1.2 | ||||||||||||
| Other | 1.1 | 0.7 | ||||||||||||
| Effective tax rate | 34.1 | % | 24.8 | % |
During fiscal 2025, state income tax expense, net of federal impact, was $36 million. Additionally, the effective tax rate was higher than the statutory rate due to the impact of a $343 million non-deductible goodwill impairment. Changes in foreign valuation allowances included a $9 million benefit due to legislation enacted in fiscal 2025.
During fiscal 2024, state income tax expense, net of federal impact, was $28 million, which included a $14 million benefit from operating loss carryforwards and a $9 million benefit related to the remeasurement of deferred income taxes, primarily due to legislation decreasing state tax rates enacted in fiscal 2024. Additionally, the effective tax rate was higher than the statutory rate due to the impact of $63 million of non-deductible goodwill associated with the sale of our Vienna, Georgia facility.
We recognize deferred income taxes for the future tax consequences attributable to differences between the financial statement carrying value of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.
The tax effects of major items recorded as deferred tax assets and liabilities as of October 3, 2026 and September 27, 2025, are as follows (in millions):
| 2026 | 2025 | ||||||||||||||||||||||
| Assets | Liabilities | Assets | Liabilities | ||||||||||||||||||||
| Property, plant and equipment | $ | — | $ | 1,024 | $ | — | $ | 1,112 | |||||||||||||||
| Intangible assets | — | 1,405 | — | 1,433 | |||||||||||||||||||
| ROU assets | — | 285 | — | 257 | |||||||||||||||||||
| Accrued expenses | 424 | — | 504 | — | |||||||||||||||||||
| Lease liabilities | 282 | — | 251 | — | |||||||||||||||||||
| Net operating loss and other carryforwards | 182 | — | 159 | — | |||||||||||||||||||
| Other | 156 | 358 | 210 | 327 | |||||||||||||||||||
| Deferred tax assets and liabilities | $ | 1,044 | $ | 3,072 | $ | 1,124 | $ | 3,129 | |||||||||||||||
| Valuation allowance | $ | (167) | $ | (173) | |||||||||||||||||||
| Net deferred tax liability | $ | 2,195 | $ | 2,178 |
At October 3, 2026, our gross state net operating loss carryforwards approximated $1,321 million, of which $1,098 million expire in fiscal years 2027 through 2046, and the remainder has no expiration. Gross foreign net operating loss carryforwards approximated $348 million, of which $133 million expire in fiscal years 2027 through 2043, and the remainder has no expiration. Gross federal capital loss carryforwards approximated $50 million and expire in fiscal year 2031. We also have tax credit carryforwards of approximately $43 million which expire in fiscal years 2027 through 2051. We maintain a valuation allowance against the majority of the deferred tax assets associated with our net operating losses and tax credit carryforwards.
Accumulated undistributed earnings of foreign subsidiaries are generally expected to be indefinitely reinvested outside of the United States, except for excess cash (net of an insignificant amount of applicable withholding taxes) not subject to regulatory requirements. Dividends after December 31, 2017 from foreign subsidiaries are generally not subject to United States federal income taxes. Accordingly, no deferred income taxes have been provided on our indefinitely reinvested earnings. Due to the uncertainty of the manner in which the outside basis difference associated with these earnings would reverse, it is not currently practicable to estimate the tax liability that might be payable on the repatriation of these foreign earnings; however, we do not expect any tax due to be material.
The following table summarizes the activity related to our gross unrecognized tax benefits as of October 3, 2026, September 27, 2025 and September 28, 2024 (in millions):
| 2026 | 2025 | 2024 | |||||||||||||||
| Balance as of the beginning of the year | $ | 168 | $ | 151 | $ | 131 | |||||||||||
| Increases related to current year tax positions | 5 | 19 | 22 | ||||||||||||||
| Increases related to prior year tax positions | 36 | 9 | 12 | ||||||||||||||
| Reductions related to prior year tax positions | (40) | (4) | (2) | ||||||||||||||
| Reductions related to settlements | (49) | (1) | — | ||||||||||||||
| Reductions related to expirations of statutes of limitations | (5) | (6) | (12) | ||||||||||||||
| Balance as of the end of the year | $ | 115 | $ | 168 | $ | 151 |
The amount of unrecognized tax benefits, if recognized, that would impact our effective tax rate was $76 million at October 3, 2026 and $110 million at September 27, 2025. We classify interest and penalties on unrecognized tax benefits as income tax expense. At October 3, 2026 and September 27, 2025, before tax benefits, we had $39 million and $73 million, respectively, of accrued interest and penalties on unrecognized tax benefits.
In December 2021, we received an assessment from the Mexican tax authorities related to the 2015 sale of our direct and indirect equity interests in subsidiaries which collectively held our Mexico operations. At October 3, 2026, the assessment totaled approximately $516 million (9.5 billion Mexican pesos), which included tax, inflation adjustment, interest and penalties. Based on analysis of our assessment in accordance with guidance related to unrecognized tax benefits, we have not recorded a liability related to our assessment. Additionally, the purchaser in the transaction also received an assessment from the Mexican tax authorities related to the sale of the indirect equity interest, which was affirmed in January 2025 by a circuit court in Mexico, but remains subject to potential further judicial review under a petition filed by the purchaser. The transaction agreement contains certain mutual indemnification provisions, and both parties provided notice of indemnification claims to the other party. On November 14, 2025, we settled the indemnification provision and entered into an agreement in which the purchaser agreed to assume all tax liabilities in connection with our assessment, assume defense of such assessment and waive all potential indemnification claims against the Company. In fiscal 2025, we recorded a pretax liability of $40 million for the estimated probable loss related to this indemnification provision, which was paid to the purchaser during the first quarter of fiscal 2026 following the settlement.
As of October 3, 2026, certain United States federal income tax returns are subject to examination for fiscal years 2021 through 2025. In the second quarter of fiscal 2026, the Internal Revenue Service (“IRS”) issued notices of proposed adjustments for fiscal years 2021 and 2022 related to our foreign-derived intangible income deductions, repair expenses and research and development tax credits. The proposed adjustments could result in additional United States federal income tax payments of up to approximately $127 million, excluding interest and penalties, if the IRS ultimately prevails on all of its positions. However, we disagree with the IRS’s positions, believe that our tax positions are well documented and properly supported, and intend to defend our positions through the administrative appeals process and litigation, if necessary. We are also subject to income tax examinations by major state and foreign jurisdictions for fiscal years 2016 through 2025 and 2021 through 2025, respectively.
NOTE 11: EARNINGS PER SHARE
The earnings and weighted average common shares used in the computation of basic and diluted earnings per share for fiscal years 2026, 2025 and 2024 are as follows (in millions, except per share data):
| 2026 | 2025 | 2024 | |||||||||||||||
| Numerator: | |||||||||||||||||
| Net income | $ | 473 | $ | 507 | $ | 822 | |||||||||||
| Less: Net income attributable to noncontrolling interests | 20 | 33 | 22 | ||||||||||||||
| Net income attributable to Tyson | 453 | 474 | 800 | ||||||||||||||
| Less dividends declared: | |||||||||||||||||
| Class A | 577 | 574 | 563 | ||||||||||||||
| Class B | 129 | 126 | 124 | ||||||||||||||
| Undistributed earnings (distributions in excess of earnings) | $ | (253) | $ | (226) | $ | 113 | |||||||||||
| Class A undistributed earnings (losses) | $ | (207) | $ | (185) | $ | 92 | |||||||||||
| Class B undistributed earnings (losses) | (46) | (41) | 21 | ||||||||||||||
| Total undistributed earnings (distributions in excess of earnings) | $ | (253) | $ | (226) | $ | 113 | |||||||||||
| Denominator: | |||||||||||||||||
| Denominator for basic earnings per share: | |||||||||||||||||
| Class A weighted average shares | 282 | 285 | 284 | ||||||||||||||
| Class B weighted average shares | 70 | 70 | 70 | ||||||||||||||
| Denominator for diluted earnings per share: | |||||||||||||||||
| Class A weighted average shares | 282 | 285 | 284 | ||||||||||||||
| Class B weighted average shares under the if-converted method for diluted earnings per share | 70 | 70 | 70 | ||||||||||||||
| Effect of dilutive securities: Stock options, restricted stock and performance units | 2 | 2 | 2 | ||||||||||||||
| Denominator for diluted earnings per share – weighted average shares and assumed conversions | 354 | 357 | 356 | ||||||||||||||
| Net income per share attributable to Tyson: | |||||||||||||||||
| Class A Basic | $ | 1.31 | $ | 1.37 | $ | 2.31 | |||||||||||
| Class B Basic | $ | 1.18 | $ | 1.22 | $ | 2.06 | |||||||||||
| Diluted | $ | 1.28 | $ | 1.33 | $ | 2.25 | |||||||||||
| Dividends Declared Per Share: | |||||||||||||||||
| Class A | $ | 2.050 | $ | 2.010 | $ | 1.970 | |||||||||||
| Class B | $ | 1.845 | $ | 1.809 | $ | 1.773 |
Approximately 5 million, 6 million and 7 million shares underlying our stock-based compensation awards were antidilutive for fiscal 2026, 2025 and 2024, respectively, and therefore were excluded from the calculation of diluted earnings per share.
We have two classes of capital stock, Class A stock and Class B stock. Cash dividends cannot be paid to holders of Class B stock unless they are simultaneously paid to holders of Class A stock. The per share amount of cash dividends paid to holders of Class B stock cannot exceed 90% of the cash dividends paid to holders of Class A stock.
We allocate undistributed earnings (losses) based upon a 1.0 to 0.9 ratio per share to Class A stock and Class B stock, respectively, which reflects our historical dividend patterns, the voting control of Class B shareholders and the contractual limitations on dividends to Class B stock.
NOTE 12: DERIVATIVE FINANCIAL INSTRUMENTS
Our business operations give rise to certain market risk exposures mostly due to changes in commodity prices, foreign currency exchange rates and interest rates. We manage a portion of these risks through the use of derivative financial instruments to reduce our exposure to commodity price risk, foreign currency risk and interest rate risk. Our risk management programs are periodically reviewed by our Board of Directors’ Audit Committee. These programs and risks are monitored by senior management and may be revised as market conditions dictate. Our current risk management programs utilize various industry-standard models that take into account the implicit cost of hedging. Credit risks associated with our derivative contracts are not significant as we minimize counterparty exposure by dealing with credit-worthy counterparties and utilizing exchange traded instruments, margin accounts or letters of credit. Additionally, our derivative contracts are mostly short term in duration and we generally do not make use of credit-risk-related contingent features. No significant concentrations of credit risk existed at October 3, 2026.
We had the following aggregated outstanding notional amounts related to our derivative financial instruments:
| in millions, except soybean meal tons | Metric | October 3, 2026 | September 27, 2025 | |||||||||||||||||
| Commodity: | ||||||||||||||||||||
| Corn | Bushels | 148 | 93 | |||||||||||||||||
| Soybean Meal | Tons | 1,582,600 | 1,221,711 | |||||||||||||||||
| Live Cattle | Pounds | 129 | 30 | |||||||||||||||||
| Lean Hogs | Pounds | 343 | 828 | |||||||||||||||||
| Foreign Currency | United States dollar | $ | 185 | $ | 208 |
We recognize all derivative instruments as either assets or liabilities at fair value in the Consolidated Balance Sheets, with the exception of normal purchases and normal sales expected to result in physical delivery. For those derivative instruments that are designated and qualify as hedging instruments, we designate the hedging instrument based upon the exposure being hedged (i.e., cash flow hedge or fair value hedge). We designate certain forward contracts as follows:
-
Cash Flow Hedges – include certain commodity forward and option contracts of forecasted purchases (i.e., grains) and interest rate swaps and locks.
-
Fair Value Hedges – include certain commodity forward contracts of firm commitments (i.e., livestock).
Cash Flow Hedges
Derivative instruments are designated as hedges against changes in the amount of future cash flows related to procurement of certain commodities utilized in our production processes and certain exposures to changes in interest rates including forecasted debt issuances and variable-rate debt. For the derivative instruments we designate and qualify as a cash flow hedge, the gain or loss on the derivative is reported as a component of other comprehensive income (“OCI”) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Based on market prices as of October 3, 2026, we have net pretax gains of $23 million for our commodity contracts, which are expected to be reclassified into earnings within the next twelve months. Additionally, we have $7 million of net pretax losses remaining in Accumulated other comprehensive income (loss) related to treasury rate locks in connection with the issuance of the 4.35% 2029 Notes and 2048 Notes, which will be reclassified to earnings over the lives of these notes. During fiscal 2026, 2025 and 2024, we did not reclassify significant pretax gains or losses into earnings as a result of the discontinuance of cash flow hedges. The following table sets forth the pretax impact of cash flow hedge derivative instruments recognized in Other Comprehensive Income (in millions):
| Gain (Loss) Recognized in OCI on Derivatives | 2026 | 2025 | 2024 | ||||||||||||||||||||||||||
| Cash flow hedge – derivatives designated as hedging instruments: | |||||||||||||||||||||||||||||
| Commodity contracts | $ | 39 | $ | (44) | $ | (8) | |||||||||||||||||||||||
Fair Value Hedges
We designate certain derivative contracts as fair value hedges of firm commitments to purchase livestock for harvest. Our objective for these hedges is to minimize the risk of changes in fair value created by fluctuations in commodity prices associated with fixed price livestock firm commitments. For these derivative instruments we designate and qualify as a fair value hedge, the gain or loss on the derivative and the change in the fair value of the hedged item attributable to the hedged risk are recognized in earnings in the same period. We include the gain or loss on the hedged items (i.e., livestock purchase firm commitments) in the same line item, Cost of Sales, as the offsetting gain or loss on the related livestock forward position. The carrying amounts associated with firm commitments accounted for as fair value hedges as of fiscal years ended 2026, 2025 and 2024 were as follows (in millions):
| Consolidated Balance Sheets Classification | 2026 | 2025 | 2024 | ||||||||||||||
| Inventories | $ | (15) | $ | 65 | $ | (3) |
Undesignated Positions
In addition to our designated positions, we also hold derivative contracts for which we do not apply hedge accounting. These include certain derivative instruments related to commodity price risk, including grains, livestock, energy and foreign currency risk. We mark these positions to fair value through earnings at each reporting date.
Reclassification to Earnings
The following table sets forth the total amounts of each income and expense line item presented in the Consolidated Statements of Income in which the effects of hedges are recorded for fiscal years ended 2026, 2025 and 2024 (in millions):
| Consolidated Statements of Income Classification | 2026 | 2025 | 2024 | ||||||||||||||
| Cost of Sales | $ | 53,189 | $ | 50,879 | $ | 49,682 | |||||||||||
| Interest expense | 406 | 449 | 481 | ||||||||||||||
| Other, net | 62 | (47) | (75) |
The following table sets forth the pretax impact of the cash flow, fair value and undesignated derivative instruments in the Consolidated Statements of Income for fiscal years ended 2026, 2025 and 2024 (in millions):
| Consolidated Statements of Income Classification | 2026 | 2025 | 2024 | |||||||||||||||||
| Cost of Sales | Gain (Loss) on cash flow hedges reclassified from OCI to earnings: | |||||||||||||||||||
| Commodity contracts | $ | (4) | $ | (33) | $ | (1) | ||||||||||||||
| Gain (Loss) on fair value hedges: | ||||||||||||||||||||
| Commodity contracts (a) | (43) | (87) | 12 | |||||||||||||||||
| Gain (Loss) on derivatives not designated as hedging instruments: | ||||||||||||||||||||
| Commodity contracts | 72 | 53 | (66) | |||||||||||||||||
| Total | $ | 25 | $ | (67) | $ | (55) | ||||||||||||||
| Interest expense | Gain (Loss) on cash flow hedges reclassified from OCI to earnings: | |||||||||||||||||||
| Interest rate contracts | $ | (2) | $ | (2) | $ | (1) | ||||||||||||||
| Other, net | Gain (Loss) on derivatives not designated as hedging instruments: | |||||||||||||||||||
| Foreign exchange contracts | $ | (10) | $ | 7 | $ | 2 | ||||||||||||||
(a) Amounts represent gains (losses) on commodity contracts designated as fair value hedges of firm commitments that were realized during the period presented, which were offset by a corresponding gain (loss) on the underlying hedged inventory. Gains or losses related to changes in the fair value of unrealized commodity contracts, along with the offsetting gain or loss on the hedged inventory, are also marked-to-market through earnings with no significant impact on a net basis.
The fair values of all outstanding derivative instruments in the Consolidated Balance Sheets are included in Note 13: Fair Value Measurements.
NOTE 13: FAIR VALUE MEASUREMENTS
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy contains three levels as follows:
Level 1 — Unadjusted quoted prices available in active markets for the identical assets or liabilities at the measurement date.
Level 2 — Other observable inputs available at the measurement date, other than quoted prices included in Level 1, either directly or indirectly, including:
-
Quoted prices for similar assets or liabilities in active markets;
-
Quoted prices for identical or similar assets in non-active markets;
-
Inputs other than quoted prices that are observable for the asset or liability; and
-
Inputs derived principally from or corroborated by other observable market data.
Level 3 — Unobservable inputs that cannot be corroborated by observable market data and reflect the use of significant management judgment. These values are generally determined using pricing models for which the assumptions utilize management’s estimates of market participant assumptions.
Assets and Liabilities Measured at Fair Value on a Recurring Basis
The fair value hierarchy requires the use of observable market data when available. In instances where the inputs used to measure fair value fall into different levels of the fair value hierarchy, the fair value measurement has been determined based on the lowest level input significant to the fair value measurement in its entirety. Our assessment of the significance of a particular item to the fair value measurement in its entirety requires judgment, including the consideration of inputs specific to the asset or liability.
The following tables set forth by level within the fair value hierarchy our financial assets and liabilities accounted for at fair value on a recurring basis according to the valuation techniques we used to determine their fair values as of October 3, 2026 and September 27, 2025 (in millions):
| October 3, 2026 | Level 1 | Level 2 | Level 3 | Netting (a) | Total | ||||||||||||||||||||||||
| Other Current Assets: | |||||||||||||||||||||||||||||
| Derivative financial instruments: | |||||||||||||||||||||||||||||
| Designated as hedges | $ | — | $ | 53 | $ | — | $ | (28) | $ | 25 | |||||||||||||||||||
| Undesignated | — | 81 | — | (41) | 40 | ||||||||||||||||||||||||
| Other Assets: | |||||||||||||||||||||||||||||
| Available-for-sale securities | — | 68 | 21 | — | 89 | ||||||||||||||||||||||||
| Deferred compensation assets | 26 | 539 | — | — | 565 | ||||||||||||||||||||||||
| Total assets | $ | 26 | $ | 741 | $ | 21 | $ | (69) | $ | 719 | |||||||||||||||||||
| Other Current Liabilities: | |||||||||||||||||||||||||||||
| Derivative financial instruments: | |||||||||||||||||||||||||||||
| Designated as hedges | $ | — | $ | 11 | $ | — | $ | (11) | $ | — | |||||||||||||||||||
| Undesignated | — | 74 | — | (61) | 13 | ||||||||||||||||||||||||
| Total liabilities | $ | — | $ | 85 | $ | — | $ | (72) | $ | 13 |
| September 27, 2025 | Level 1 | Level 2 | Level 3 | Netting (a) | Total | ||||||||||||||||||||||||
| Other Current Assets: | |||||||||||||||||||||||||||||
| Derivative financial instruments: | |||||||||||||||||||||||||||||
| Designated as hedges | $ | — | $ | 6 | $ | — | $ | (1) | $ | 5 | |||||||||||||||||||
| Undesignated | — | 113 | — | (20) | 93 | ||||||||||||||||||||||||
| Other Assets: | |||||||||||||||||||||||||||||
| Available-for-sale securities | — | 90 | 27 | — | 117 | ||||||||||||||||||||||||
| Deferred compensation assets | 21 | 501 | — | — | 522 | ||||||||||||||||||||||||
| Total assets | $ | 21 | $ | 710 | $ | 27 | $ | (21) | $ | 737 | |||||||||||||||||||
| Other Current Liabilities: | |||||||||||||||||||||||||||||
| Derivative financial instruments: | |||||||||||||||||||||||||||||
| Designated as hedges | $ | — | $ | 82 | $ | — | $ | (82) | $ | — | |||||||||||||||||||
| Undesignated | — | 135 | — | (126) | 9 | ||||||||||||||||||||||||
| Total liabilities | $ | — | $ | 217 | $ | — | $ | (208) | $ | 9 |
(a) Our derivative assets and liabilities are presented in our Consolidated Balance Sheets on a net basis when a legally enforceable master netting arrangement exists between the counterparty to a derivative contract and us. Additionally, at October 3, 2026 and September 27, 2025, we had $3 million and $187 million, respectively, of net cash collateral posted with various counterparties where master netting arrangements exist and held no significant cash collateral.
The following table provides a reconciliation between the beginning and ending balance of marketable debt securities measured at fair value on a recurring basis in the table above that used significant unobservable inputs (Level 3) as of October 3, 2026 and September 27, 2025 (in millions):
| October 3, 2026 | September 27, 2025 | ||||||||||
| Balance at beginning of year | $ | 27 | $ | 28 | |||||||
| Purchases | 11 | 9 | |||||||||
| Settlements | (17) | (10) | |||||||||
| Balance at end of year | $ | 21 | $ | 27 |
The following methods and assumptions were used to estimate the fair value of each class of financial instrument:
Derivative Assets and Liabilities
Our derivative financial instruments primarily include exchange-traded and over-the-counter contracts which are further described in Note 12: Derivative Financial Instruments. We record our derivative financial instruments at fair value using quoted market prices, adjusted where necessary for credit and non-performance risk and internal models that use readily observable market inputs as their basis, including current and forward market prices and rates. We classify these instruments in Level 2 when quoted market prices can be corroborated utilizing observable current and forward commodity market prices on active exchanges or observable market transactions.
Available-for-Sale Securities
Our investments in marketable debt securities are classified as available for sale and are reported at fair value based on pricing models and quoted market prices adjusted for credit and non-performance risk. These securities are included in Other Assets in the Consolidated Balance Sheets and have maturities ranging up to 44 years.
We classify our investments in U.S. treasury and agency securities, certificates of deposit and commercial paper debt securities as Level 2 as fair value is generally estimated using discounted cash flow models that are primarily industry-standard models that consider various assumptions, including time value and yield curve as well as other readily available relevant economic measures. We classify certain corporate, asset-backed and other debt securities as Level 3 as there is limited activity or less observable inputs into valuation models, including current interest rates and estimated prepayment, default and recovery rates on the underlying portfolio or structured investment vehicle. Significant changes to assumptions or unobservable inputs in the valuation of our Level 3 instruments would not have a significant impact on our consolidated financial statements.
The following table sets forth our available-for-sale securities’ amortized cost basis, fair value and unrealized gain (loss) by significant investment category as of October 3, 2026 and September 27, 2025 (in millions):
| October 3, 2026 | September 27, 2025 | ||||||||||||||||||||||||||||||||||
| Amortized Cost Basis | Fair Value | Unrealized Gain/(Loss) | Amortized Cost Basis | Fair Value | Unrealized Gain/(Loss) | ||||||||||||||||||||||||||||||
| Debt securities: | |||||||||||||||||||||||||||||||||||
| U.S. treasury and agency | $ | 72 | $ | 68 | $ | (4) | $ | 91 | $ | 90 | $ | (1) | |||||||||||||||||||||||
| Corporate and asset-backed | 21 | 21 | — | 27 | 27 | — |
Unrealized gains (losses), net of tax, are excluded from earnings and reported in OCI until the security is settled or sold. On a quarterly basis, we evaluate whether losses related to our available-for-sale securities are due to credit or non-credit factors. Losses on debt securities where we have the intent, or will more than likely be required, to sell the security prior to recovery, would be recorded as a direct write-off of amortized cost basis through earnings. Losses on debt securities where we do not have the intent, or would not more than likely be required to sell the security prior to recovery, would be further evaluated to determine whether the loss is credit or non-credit related. Credit-related losses would be recorded through an allowance for credit losses through earnings and non-credit related losses through OCI.
We consider many factors in determining whether a loss is credit-related, including the financial condition and near-term prospects of the issuer, borrower repayment characteristics for asset-backed securities and our ability and intent to hold the investment for a period of time sufficient to allow for any anticipated recovery. We recognized no direct write-offs or allowances for credit losses in earnings in fiscal 2026, 2025 or 2024.
Deferred Compensation Assets
We maintain non-qualified deferred compensation plans for certain executives and other highly compensated team members. Investments are generally maintained within a trust and include money market funds, mutual funds and life insurance policies. The cash surrender value of the life insurance policies is invested primarily in mutual funds. The investments are recorded at fair value based on quoted market prices and are included in Other Assets in the Consolidated Balance Sheets. We classify the investments which have observable market prices in active markets in Level 1 as these are generally publicly traded mutual funds. The remaining deferred compensation assets are classified in Level 2 as fair value can be corroborated based on observable market data. Realized and unrealized gains (losses) on deferred compensation are included in earnings.
Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis
In addition to assets and liabilities that are recorded at fair value on a recurring basis, we record assets and liabilities at fair value on a nonrecurring basis. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges and, with respect to our equity investments without readily determinable fair values, recorded by applying the measurement alternative for which such investments are recorded at cost and adjusted for an observable price change in an orderly transaction for an identical or similar investment of the same issuer.
During fiscal 2026, we recorded a fixed asset impairment charge of $217 million as a result of our decision to close two production facilities. This charge was recorded in Cost of Sales in the Consolidated Statements of Income. The fair value of the assets was determined using Level 3 inputs, including discounted cash flows and market-based valuation techniques. Additionally, we recorded impairment charges of $81 million in Other, net in the Consolidated Statements of Income related to our equity investments. These equity investments, included in Other Assets in the Consolidated Balance Sheets, do not have readily determinable fair values and were measured using a market approach that utilized Level 3 inputs.
During fiscal 2025, we recorded a goodwill impairment charge of $343 million in our Beef segment. We estimated the fair value utilizing an income approach (discounted cash flow method) valuation technique, which incorporated significant unobservable Level 3 inputs. Additionally, in fiscal 2025, we recorded a fixed asset impairment charge of $19 million as a result of our decision to sell a storage facility. This charge was recorded in Cost of Sales in the Consolidated Statements of Income and was derived using Level 3 inputs, including management’s estimate of the proceeds from the disposal of the asset. We also recorded impairment charges of $28 million in Other, net in the Consolidated Statements of Income, related to our equity investments, including $24 million accounted for under the equity method. These equity investments are included in Other Assets in the Consolidated Balance Sheets, do not have readily determinable fair values and were measured using a market approach which utilized Level 3 inputs.
During fiscal 2024, we recorded a fixed asset impairment charge of $33 million in Cost of Sales in the Consolidated Statements of Income as a result of our decision to sell our Netherlands facility. The charge was derived using Level 3 inputs and was driven by management’s estimate of the potential proceeds from the disposal of the assets. We did not have any other significant measurements of assets or liabilities at fair value on a nonrecurring basis subsequent to their initial recognition during the twelve months ended October 3, 2026, September 27, 2025 or September 28, 2024.
Other Financial Instruments
Fair value of our debt is principally estimated using Level 2 inputs based on quoted prices for those or similar instruments. Fair value and carrying value for our debt are as follows as of October 3, 2026 and September 27, 2025 (in millions):
| October 3, 2026 | September 27, 2025 | ||||||||||||||||||||||
| Fair Value | Carrying Value | Fair Value | Carrying Value | ||||||||||||||||||||
| Total Debt | $ | 7,204 | $ | 7,750 | $ | 8,658 | $ | 8,830 |
Concentrations of Credit Risk
Our financial instruments exposed to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. Our cash equivalents are in high-quality securities placed with major banks and financial institutions. Concentrations of credit risk with respect to receivables are limited due to the large number of customers and their dispersion across geographic areas. We perform periodic credit evaluations of our customers’ financial condition and generally do not require collateral. At October 3, 2026 and September 27, 2025, 18.6% and 15.6%, respectively, of our net accounts receivable balance was due from Walmart Inc. No other single customer or customer group represented greater than 10% of net accounts receivable.
NOTE 14: STOCK-BASED COMPENSATION
The Tyson Foods, Inc. 2000 Stock Incentive Plan (“Incentive Plan”) was initially approved by shareholders in January 2001 and most recently amended and restated as of February 5, 2026, and is administered by the Compensation and Leadership Development Committee of the Board of Directors (“Compensation Committee”). We issue shares under the Incentive Plan from treasury stock. As of October 3, 2026, 8,262,724 shares were available for future grants under the Incentive Plan.
Stock Options
The Incentive Plan includes provisions for granting incentive stock options for shares of Class A stock at a price not less than the fair value at the date of grant. Non-qualified stock options may be granted at a price equal to or greater than the fair value of Class A stock on the date of grant. Stock options under the Incentive Plan generally become exercisable ratably over three years from the date of grant and must be exercised within 10 years from the date of grant. Our policy is to recognize compensation expense on a straight-line basis over the requisite service period for the entire award. Forfeitures are recognized as they occur. No stock options were granted in fiscal 2026.
| Shares Under Option | Weighted Average Exercise Price Per Share | Weighted Average Remaining Contractual Life (in Years) | Aggregate Intrinsic Value (in millions) | ||||||||||||||||||||
| Outstanding, September 27, 2025 | 7,470,159 | $ | 65.19 | ||||||||||||||||||||
| Exercised | (624,991) | 54.11 | |||||||||||||||||||||
| Forfeited or expired | (823,861) | 75.87 | |||||||||||||||||||||
| Outstanding, October 3, 2026 | 6,021,307 | $ | 64.88 | 5.7 | $ | 4 | |||||||||||||||||
| Exercisable, October 3, 2026 | 4,698,823 | $ | 66.42 | 5.1 | $ | 3 |
The weighted average grant-date fair value of options granted in fiscal 2025 and 2024 was $13.94 and $12.70, respectively. The fair value of each option grant is determined on the date of grant using a binomial lattice method. We use historical volatility for a period of time comparable to the expected life of the option to determine volatility assumptions. Expected life is calculated based on the contractual term of each grant and takes into account the historical exercise and termination behavior of participants. Risk-free interest rates are based on the five-year Treasury yield. Assumptions used in the fair value calculation are as of the grant dates and are outlined in the following table.
| 2025 | 2024 | ||||||||||||||||
| Expected life (in years) | 4.6 | 4.5 | |||||||||||||||
| Risk-free interest rate | 4.2 | % | 4.5 | % | |||||||||||||
| Expected volatility | 26.8 | % | 31.9 | % | |||||||||||||
| Expected dividend yield | 3.0 | % | 2.7 | % |
As of October 3, 2026, we had $4 million of total unrecognized compensation cost related to stock option plans that will be recognized over a weighted-average period of 1.1 years.
We recognized stock-based compensation expense related to stock options, net of income taxes, of $5 million, $19 million and $19 million for fiscal 2026, 2025 and 2024, respectively. The related tax benefits were $1 million, $3 million and $3 million for fiscal 2026, 2025 and 2024, respectively. We had 1.2 million, 1.1 million and 1.1 million options vest in fiscal 2026, 2025 and 2024, respectively, with a grant date fair value of $17 million, $16 million and $15 million, respectively.
In fiscal 2026, 2025 and 2024, we received cash of $27 million, $21 million and $14 million, respectively, from the exercise of stock options. The related tax benefits realized from stock options exercised during fiscal 2026, 2025 and 2024, were $1 million, $2 million and $1 million, respectively. The total intrinsic value of options exercised in fiscal 2026, 2025 and 2024, was $2 million, $3 million and $2 million, respectively.
Restricted Stock
We issue restricted stock awards and units based on the market value of our Class A stock on the date of grant, with restrictions expiring over periods through fiscal 2029. Beginning in fiscal 2025, we changed from granting restricted stock awards to restricted stock units which generally vest one-third each year over a three-year period from the date of the grant and include dividend equivalent provisions under which additional restricted stock units are issued upon the payment of dividends to Class A shareholders. The fair value of each restricted stock unit is based on the Class A stock price on the date of the grant and compensation expense is recognized ratably over the requisite service period.
| Number of Awards or Units | Weighted Average Grant- Date Fair Value Per Share/Unit | Weighted Average Remaining Contractual Life (in Years) | Aggregate Intrinsic Value (in millions) | ||||||||||||||||||||
| Nonvested, September 27, 2025 | 1,696,285 | $ | 59.26 | ||||||||||||||||||||
| Granted | 1,265,316 | 57.42 | |||||||||||||||||||||
| Dividends | 68,000 | 57.90 | |||||||||||||||||||||
| Vested | (941,901) | 59.48 | |||||||||||||||||||||
| Forfeited | (143,363) | 57.11 | |||||||||||||||||||||
| Nonvested, October 3, 2026 | 1,944,337 | $ | 58.07 | 1.7 | $ | 101 |
As of October 3, 2026, we had $41 million of total unrecognized compensation cost related to restricted stock awards and units that will be recognized over a weighted-average period of 2.0 years.
We recognized stock-based compensation expense related to restricted stock awards and units, net of income taxes, of $49 million, $39 million and $39 million for fiscal 2026, 2025 and 2024, respectively. The related tax benefits for fiscal 2026, 2025 and 2024 were $10 million, $8 million and $9 million, respectively. We had 0.9 million, 0.9 million and 0.6 million restricted stock awards and units vest in fiscal 2026, 2025 and 2024, respectively, with grant date fair values of $56 million, $55 million and $41 million, respectively.
Performance-Based Shares
We award performance-based shares of our Class A stock to certain team members. These awards are typically granted once a year. Performance-based shares vest based upon the passage of time and the achievement of performance or market conditions, with payouts ranging from 0% to 200% of the target award, as determined by the Compensation Committee prior to the date of the award. Vesting periods for these awards are typically three years.
We assess the probability of achieving performance conditions each quarter during the requisite service period. When achievement of the minimum performance condition becomes probable, we recognize compensation expense based on the grant-date fair value of the award, which generally will be the Class A stock price on the grant date, and the number of shares expected to vest based on the estimated level of achievement. The total expense recognized over the duration of awards with performance conditions will generally equal the Class A stock price on the date of grant multiplied by the number of shares ultimately awarded based on the level of attainment of the performance criteria. For awards with market conditions, grant-date fair value is determined using a valuation model incorporating the applicable market condition and is generally calculated using the same inputs for expected volatility, expected dividend yield and risk-free interest rate as stock options, noted above, with a duration of three years. The total expense recognized over the duration of the award will equal the grant-date fair value, regardless of whether the market condition is met, provided the requisite service condition is satisfied.
The following table summarizes the performance-based shares at the maximum award amounts under the respective performance share agreements. The actual number of shares that will vest depends on the level of attainment of the applicable performance conditions.
| Number of Awards | Weighted Average Grant- Date Fair Value Per Share | Weighted Average Remaining Contractual Life (in Years) | Aggregate Intrinsic Value (in millions) | ||||||||||||||||||||
| Nonvested, September 27, 2025 | 2,495,890 | $ | 46.63 | ||||||||||||||||||||
| Granted | 1,033,049 | 46.14 | |||||||||||||||||||||
| Vested | (153,098) | 48.74 | |||||||||||||||||||||
| Forfeited | (829,437) | 48.43 | |||||||||||||||||||||
| Nonvested, October 3, 2026 | 2,546,404 | $ | 45.72 | 1.1 | $ | 132 |
As of October 3, 2026, we had $21 million of total unrecognized compensation cost based upon our progress toward the attainment of criteria related to performance-based share awards that will be recognized over a weighted-average period of 1.8 years.
We recognized stock-based compensation expense related to performance shares, net of income taxes, of $48 million, $28 million and $25 million for fiscal 2026, 2025 and 2024, respectively. The related tax benefits for fiscal 2026, 2025 and 2024 were $3 million, $3 million and $4 million, respectively.
NOTE 15: PENSIONS AND OTHER POSTRETIREMENT BENEFITS
We have four defined benefit pension plans consisting of one frozen noncontributory funded qualified plan and three frozen unfunded non-qualified plans. The benefits provided under these plans are based on a formula using years of service and either a specified benefit rate or compensation level. The non-qualified defined benefit plans are for certain officers and use a formula based on years of service and final average salary. We also have other postretirement benefit plans for which substantially all of our team members may receive benefits if they satisfy applicable eligibility criteria. The postretirement healthcare plans are contributory with participants’ contributions adjusted when deemed necessary.
We use a fiscal year-end measurement date for our defined benefit plans and other postretirement plans. We recognize the effect of actuarial gains and losses into earnings immediately for other postretirement plans rather than amortizing the effect over future periods. Other postretirement benefits include postretirement medical costs and life insurance.
During fiscal 2026, we discontinued participation in a multi-employer pension plan and recognized an $18 million expense in Other, net in our Consolidated Statements of Income. We expect to fund the $18 million obligation in fiscal 2027. In fiscal 2024, we amended and discontinued one of the Company’s other postretirement benefit plans which resulted in the recognition of a gain of $16 million, recorded in Other, net in our Consolidated Statements of Income.
Additionally, we have defined contribution retirement programs for various groups of team members and recognized expenses of $117 million, $114 million and $111 million in fiscal 2026, 2025 and 2024, respectively.
Benefit Obligations and Funded Status
The following table provides a reconciliation of the changes in the plans’ benefit obligations, assets and funded status as of October 3, 2026 and September 27, 2025 (in millions):
| Pension Benefits | Other Postretirement | ||||||||||||||||||||||||||||||||||
| Qualified | Non-Qualified | Benefits | |||||||||||||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||||||||||||
| Change in benefit obligation: | |||||||||||||||||||||||||||||||||||
| Benefit obligation at beginning of year | $ | 20 | $ | 21 | $ | 156 | $ | 167 | $ | 31 | $ | 34 | |||||||||||||||||||||||
| Service cost | — | — | — | — | 2 | 2 | |||||||||||||||||||||||||||||
| Interest cost | 1 | 1 | 8 | 7 | 1 | 1 | |||||||||||||||||||||||||||||
| Actuarial (gain)/loss | — | (1) | (12) | (4) | — | (3) | |||||||||||||||||||||||||||||
| Benefits paid | (1) | (1) | (15) | (14) | (8) | (3) | |||||||||||||||||||||||||||||
| Benefit obligation at end of year | 20 | 20 | 137 | 156 | 26 | 31 | |||||||||||||||||||||||||||||
| Change in plan assets: | |||||||||||||||||||||||||||||||||||
| Fair value of plan assets at beginning of year | 30 | 30 | — | — | — | — | |||||||||||||||||||||||||||||
| Actual return on plan assets | 3 | 1 | — | — | — | — | |||||||||||||||||||||||||||||
| Employer contributions | — | — | 15 | 14 | 8 | 3 | |||||||||||||||||||||||||||||
| Benefits paid | (1) | (1) | (15) | (14) | (8) | (3) | |||||||||||||||||||||||||||||
| Fair value of plan assets at end of year | 32 | 30 | — | — | — | — | |||||||||||||||||||||||||||||
| Funded status | $ | 12 | $ | 10 | $ | (137) | $ | (156) | $ | (26) | $ | (31) |
Amounts recognized in the Consolidated Balance Sheets as of October 3, 2026 and September 27, 2025 consist of (in millions):
| Pension Benefits | Other Postretirement | ||||||||||||||||||||||||||||||||||
| Qualified | Non-Qualified | Benefits | |||||||||||||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||||||||||||
| Other assets | $ | 12 | $ | 10 | $ | — | $ | — | $ | — | $ | — | |||||||||||||||||||||||
| Other current liabilities | — | — | (14) | (14) | (2) | (8) | |||||||||||||||||||||||||||||
| Other liabilities | — | — | (123) | (142) | (24) | (23) | |||||||||||||||||||||||||||||
| Total assets (liabilities) | $ | 12 | $ | 10 | $ | (137) | $ | (156) | $ | (26) | $ | (31) |
Pretax amounts recognized in Accumulated Other Comprehensive Income as of October 3, 2026 and September 27, 2025 consist of (in millions):
| Pension Benefits | Other Postretirement | ||||||||||||||||||||||||||||||||||
| Qualified | Non-Qualified | Benefits | |||||||||||||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||||||||||||
| Accumulated other comprehensive (income) loss: | |||||||||||||||||||||||||||||||||||
| Actuarial (gain) loss | $ | — | $ | 1 | $ | (15) | $ | (3) | $ | — | $ | — | |||||||||||||||||||||||
| Prior service (credit) cost | — | — | — | — | — | — | |||||||||||||||||||||||||||||
| Total accumulated other comprehensive (income) loss | $ | — | $ | 1 | $ | (15) | $ | (3) | $ | — | $ | — |
As of October 3, 2026 and September 27, 2025, we had three pension plans that had an accumulated benefit obligation in excess of plan assets. Plans with accumulated benefit obligations in excess of plan assets are as follows (in millions):
| Pension Benefits | |||||||||||||||||||||||
| Qualified | Non-Qualified | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Projected benefit obligation | $ | — | $ | — | $ | 137 | $ | 156 | |||||||||||||||
| Accumulated benefit obligation | — | — | 137 | 156 | |||||||||||||||||||
| Fair value of plan assets | — | — | — | — |
The accumulated benefit obligation for the qualified pension plan was $20 million as of October 3, 2026 and September 27, 2025.
Net Periodic Benefit Cost (Credit)
Components of net periodic benefit cost (credit) for pension and postretirement benefit plans recognized in the Consolidated Statements of Income for fiscal years ended 2026, 2025 and 2024 are as follows (in millions):
| Pension Benefits | Other Postretirement | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Qualified | Non-Qualified | Benefits | |||||||||||||||||||||||||||||||||||||||||||||||||||
| 2026 | 2025 | 2024 | 2026 | 2025 | 2024 | 2026 | 2025 | 2024 | |||||||||||||||||||||||||||||||||||||||||||||
| Service cost | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | $ | 2 | $ | 2 | $ | 2 | |||||||||||||||||||||||||||||||||||
| Interest cost | 1 | 1 | 1 | 8 | 7 | 9 | 1 | 1 | 1 | ||||||||||||||||||||||||||||||||||||||||||||
| Expected return on plan assets | (2) | (2) | (1) | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||
| Amortization of prior service cost | — | — | — | — | — | 1 | — | — | 4 | ||||||||||||||||||||||||||||||||||||||||||||
| Recognized actuarial loss (gain), net | — | — | — | — | — | (2) | — | 1 | — | ||||||||||||||||||||||||||||||||||||||||||||
| Net periodic benefit cost (credit) | $ | (1) | $ | (1) | $ | — | $ | 8 | $ | 7 | $ | 8 | $ | 3 | $ | 4 | $ | 7 |
Each of the components, other than the service cost component, was recorded in Other, net in the Consolidated Statements of Income. As of October 3, 2026, we expect no amounts in accumulated other comprehensive income related to the qualified pension plan to be reclassified into earnings within the next 12 months. Amounts expected to be reclassified into earnings within the next 12 months related to the non-qualified pension plans and the other postretirement benefit plans are not significant.
Assumptions
Weighted average assumptions for fiscal years ended 2026, 2025 and 2024 are as follows:
| Pension Benefits | Other Postretirement | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Qualified | Non-Qualified | Benefits | |||||||||||||||||||||||||||||||||||||||||||||||||||
| 2026 | 2025 | 2024 | 2026 | 2025 | 2024 | 2026 | 2025 | 2024 | |||||||||||||||||||||||||||||||||||||||||||||
| Discount rate to determine net periodic benefit cost | 6.00 | % | 5.00 | % | 5.70 | % | 5.26 | % | 4.85 | % | 5.79 | % | 2.69 | % | 3.44 | % | 4.92 | % | |||||||||||||||||||||||||||||||||||
| Discount rate to determine benefit obligations | 6.50 | % | 6.00 | % | 5.00 | % | 6.43 | % | 5.26 | % | 4.85 | % | 2.91 | % | 2.69 | % | 3.44 | % | |||||||||||||||||||||||||||||||||||
| Rate of compensation increase | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | ||||||||||||||||||||||||||||||||||||||||||||
| Expected return on plan assets | 6.50 | % | 5.00 | % | 5.70 | % | n/a | n/a | n/a | n/a | n/a | n/a |
To determine the expected return on plan assets assumption, we first examined historical rates of return for the various asset classes within the plans. We then determined a long-term projected rate of return based on expected returns. Our discount rate assumptions used to account for pension and other postretirement benefit plans reflect the rates at which the benefit obligations could be effectively settled. The discount rates for our plans were determined using a cash flow matching technique whereby the rates of a yield curve, developed from high-quality debt securities, were applied to the benefit obligations to determine the appropriate discount rate.
We have seven other postretirement benefit plans, of which five are healthcare and life insurance related. Two of these plans, with benefit obligations totaling $6 million at October 3, 2026, were not impacted by healthcare cost trend rates as one consists of fixed annual payments and one is life insurance related. Two of the healthcare plans, with benefit obligations less than $1 million at October 3, 2026, were not impacted by healthcare cost trend rates due to previous plan amendments. The remaining plan, with benefit obligations less than $3 million at October 3, 2026, utilized an assumed healthcare cost trend rate of 9.3% that will be grading down to an ultimate rate of 4.5% in 2036.
Contributions
Our policy is to fund at least the minimum contribution required to meet applicable legal and regulatory requirements. In our sole discretion, we may from time to time fund additional amounts. Expected contributions to pension plans for fiscal 2027 are approximately $14 million. For fiscal 2026, 2025 and 2024, we funded $15 million, $14 million and $14 million, respectively, to pension plans.
Estimated Future Benefit Payments
The following benefit payments are expected to be paid (in millions):
| Pension Benefits | Other Postretirement | ||||||||||||||||
| Qualified | Non-Qualified | Benefits | |||||||||||||||
| 2027 | $ | — | $ | 14 | $ | 2 | |||||||||||
| 2028 | 1 | 13 | 2 | ||||||||||||||
| 2029 | 1 | 13 | 2 | ||||||||||||||
| 2030 | 1 | 13 | 2 | ||||||||||||||
| 2031 | 2 | 12 | 2 | ||||||||||||||
| 2032-2036 | 4 | 57 | 6 |
The above benefit payments for other postretirement benefit plans are not expected to be offset by Medicare Part D subsidies in fiscal 2027.
NOTE 16: COMPREHENSIVE INCOME
The before and after tax changes in the components of other comprehensive income for fiscal years ended 2026, 2025 and 2024 are as follows (in millions):
| 2026 | 2025 | 2024 | ||||||||||||||||||||||||||||||||||||
| Before Tax | Tax | After Tax | Before Tax | Tax | After Tax | Before Tax | Tax | After Tax | ||||||||||||||||||||||||||||||
| Derivatives accounted for as cash flow hedges: | ||||||||||||||||||||||||||||||||||||||
| (Gain) loss reclassified to interest expense | $ | 2 | $ | (1) | $ | 1 | $ | 2 | $ | — | $ | 2 | $ | 1 | $ | — | $ | 1 | ||||||||||||||||||||
| (Gain) loss reclassified to cost of sales | 4 | (1) | 3 | 33 | (9) | 24 | 1 | — | 1 | |||||||||||||||||||||||||||||
| Unrealized gain (loss) | 39 | (10) | 29 | (44) | 11 | (33) | (9) | 2 | (7) | |||||||||||||||||||||||||||||
| Investments: | ||||||||||||||||||||||||||||||||||||||
| Unrealized gain (loss) | (3) | 1 | (2) | — | — | — | 5 | (1) | 4 | |||||||||||||||||||||||||||||
| Currency translation: | ||||||||||||||||||||||||||||||||||||||
| Translation adjustment (a) | 11 | 3 | 14 | (9) | 2 | (7) | 103 | (3) | 100 | |||||||||||||||||||||||||||||
| Translation loss reclassified to earnings (b) | 19 | — | 19 | 3 | — | 3 | — | — | — | |||||||||||||||||||||||||||||
| Postretirement benefits: | ||||||||||||||||||||||||||||||||||||||
| Unrealized gain (loss) | 13 | (3) | 10 | 5 | (1) | 4 | (12) | 3 | (9) | |||||||||||||||||||||||||||||
| Total other comprehensive income (loss) | $ | 85 | $ | (11) | $ | 74 | $ | (10) | $ | 3 | $ | (7) | $ | 89 | $ | 1 | $ | 90 |
(a) The before and after tax currency translation adjustment for fiscal years 2026, 2025 and 2024 included $(1) million, none and $14 million, respectively, attributable to noncontrolling interest.
(b) In fiscal 2026, we reclassified $19 million of accumulated foreign currency translation losses from accumulated other comprehensive income to Other, net, upon the disposition of an equity method investment. In fiscal 2025, we reclassified $3 million of accumulated foreign currency translation losses from accumulated other comprehensive income to cost of sales.
The components of accumulated other comprehensive income (loss) as of October 3, 2026 and September 27, 2025 are as follows (in millions):
| 2026 | 2025 | ||||||||||
| Accumulated other comprehensive income (loss), net of taxes: | |||||||||||
| Unrealized net hedging gain (loss) | $ | 11 | $ | (22) | |||||||
| Unrealized net loss on investments | (3) | (1) | |||||||||
| Currency translation adjustment | (136) | (170) | |||||||||
| Postretirement benefits reserve adjustments | 12 | 2 | |||||||||
| Total accumulated other comprehensive income (loss) | $ | (116) | $ | (191) |
NOTE 17: SEGMENT REPORTING
We operate in five reportable segments: Beef, Pork, Chicken, Prepared Foods and International. We measure segment profit as segment operating income (loss). Prior to fiscal 2026, International was a non-reportable segment and was presented within International/Other. Effective in the first quarter of fiscal 2026, International was identified as a reportable segment.
Our President and Chief Executive Officer is the Chief Operating Decision Maker (“CODM”) of the Company. Commencing in the first quarter of fiscal 2026, we no longer allocate corporate expenses and amortization to our segments as these items are no longer used by our CODM in assessing the performance of, and in allocating resources to, the segments. The CODM uses segment operating income (loss) as the segment profitability measure to assess performance and allocate resources. Segment operating income (loss) is now defined as Operating Income (Loss) excluding corporate expenses and amortization to reflect these changes. Corporate expenses are unallocated general and administrative costs, including the costs of corporate functions, that are shared across multiple segments. Amortization includes amortization of intangible assets, including brands and trademarks, customer relationships, supply arrangements, patents and intellectual property and land use rights, as well as amortization of software. Segment operating income (loss) is used in our budgeting and forecasting processes to assess profitability and to inform decisions regarding strategic initiatives and capital investments across our reportable segments. Our CODM considers variances of actual performance to our annual operating plan and periodic forecasts when making decisions.
All prior periods have been recast to reflect the new presentation of segment operating income (loss) and International as a reportable segment. Refer to Note 1: Business and Summary of Significant Accounting Policies for additional description.
Significant expenses are expenses which are regularly provided to the CODM and are included in segment operating income (loss). These consist of segment cost of sales, segment selling, general and administrative expenses and various items affecting comparability. Segment cost of sales includes raw materials, direct labor, plant overhead, purchasing and receiving costs, costs directly related to production planning, food safety and quality assurance costs and transportation and warehousing expenses, excluding items affecting comparability. Segment selling, general and administrative expenses include the costs to execute sales to customers, costs related to selling, marketing, advertising and promotional activities and other general and administrative operating costs that are not directly related to manufacturing as well as other expense items, excluding items affecting comparability. Items affecting comparability include restructuring and related charges (including network optimization), plant closure and disposal charges (net of gains), goodwill and intangible impairments, brand and product line discontinuations, facility fire-related costs (net of insurance proceeds) and certain non-ordinary course legal, regulatory and other matters.
Beef
Beef includes our operations related to processing live fed cattle and fabricating dressed beef carcasses into primal and sub-primal cuts and case-ready products. Products are marketed domestically to food retailers, foodservice distributors, restaurant operators, hotel chains and noncommercial foodservice establishments such as schools, healthcare facilities, the military and other food processors, as well as to international export markets. This segment also includes sales from specialty products such as hides, rendered products and variety meats, as well as logistics operations to move products through the supply chain.
Pork
Pork includes our operations related to processing live market hogs and fabricating pork carcasses into primal and sub-primal cuts and case-ready products. Products are marketed domestically to food retailers, foodservice distributors, restaurant operators, hotel chains and noncommercial foodservice establishments such as schools, healthcare facilities, the military and other food processors, as well as to international export markets. This segment also includes our live swine group, specialty product processing activities and logistics operations to move products through the supply chain.
Chicken
Chicken includes our domestic operations related to raising and processing live chickens into and purchasing raw materials for fresh, frozen and value-added chicken products, as well as sales from specialty products. Our value-added chicken products primarily include breaded chicken strips, nuggets, patties and other ready-to-fix or fully cooked chicken parts. Products are marketed domestically to food retailers, foodservice distributors, restaurant operators, convenience stores, hotel chains and noncommercial foodservice establishments such as schools, healthcare facilities, the military and other food processors, as well as to international export markets. This segment also includes logistics operations to move products through our domestic supply chain and the global operations of our chicken breeding stock subsidiary.
Prepared Foods
Prepared Foods includes our operations related to manufacturing and marketing frozen and refrigerated food products and logistics operations to move products through the supply chain. This segment includes brands such as Jimmy Dean®, Hillshire Farm®, Ball Park®, Wright® and State Fair®, as well as the artisanal brands aidells® and Gallo Salame®. Products primarily include a mixture of ready-to-cook and ready-to-eat sandwiches, sandwich components such as flame-grilled hamburgers and Philly steaks, pepperoni, bacon, breakfast sausage, turkey, lunchmeat, hot dogs, flour and corn tortilla products, appetizers, snacks, prepared meals, ethnic foods, side dishes, meat dishes, breadsticks and processed meats. Products are marketed domestically to food retailers, foodservice distributors, restaurant operators, convenience stores, hotel chains and noncommercial foodservice establishments such as schools, healthcare facilities, the military and other food processors, as well as to international export markets.
International
International includes our foreign operations in China, Europe, Malaysia, Mexico, South Korea, Thailand and the Kingdom of Saudi Arabia related to raising and processing live chickens into and purchasing raw materials for fresh, frozen and value-added chicken products, as well as the distribution of chicken products and other protein and non-protein food products. Products are marketed to foodservice distributors and retailers and to other international markets.
Intersegment sales transactions, which are at market prices, are included in the segment sales in the tables below. Expenses, amortization, assets and additions to property, plant and equipment relating to corporate activities, as well as cash and cash equivalents, benefit plan assets and liabilities and certain investments, are not allocated to segments in the tables below.
Information on segments and a reconciliation to Income before Income Taxes for fiscal years ended 2026, 2025 and 2024 are as follows (in millions):
| Twelve months ended October 3, 2026 | |||||||||||||||||||||||||||||||||||||||||||||||
| Beef | Pork | Chicken | Prepared Foods | International | Intersegment | Total | |||||||||||||||||||||||||||||||||||||||||
| Sales(a) | $ | 21,662 | $ | 6,328 | $ | 17,564 | $ | 10,495 | $ | 2,427 | $ | (2,057) | $ | 56,419 | |||||||||||||||||||||||||||||||||
| Segment Cost of Sales | 22,042 | 6,026 | 15,060 | 8,535 | 2,090 | (2,021) | |||||||||||||||||||||||||||||||||||||||||
| Segment Selling, General and Administrative | 79 | 32 | 400 | 431 | 109 | — | |||||||||||||||||||||||||||||||||||||||||
| Restructuring and related charges | 358 | 22 | 12 | 31 | — | — | |||||||||||||||||||||||||||||||||||||||||
| Legal contingency accruals | — | — | 30 | — | 5 | — | |||||||||||||||||||||||||||||||||||||||||
| Other segment items(b) | 398 | 111 | 313 | 172 | 44 | (36) | |||||||||||||||||||||||||||||||||||||||||
| Segment Operating Income (Loss) | $ | (1,215) | $ | 137 | $ | 1,749 | $ | 1,326 | $ | 179 | $ | — | $ | 2,176 | |||||||||||||||||||||||||||||||||
| Corporate expenses(c) | (856) | ||||||||||||||||||||||||||||||||||||||||||||||
| Amortization(d) | (220) | ||||||||||||||||||||||||||||||||||||||||||||||
| Operating Income (Loss) | $ | 1,100 | |||||||||||||||||||||||||||||||||||||||||||||
| Other (Income) Expense: | |||||||||||||||||||||||||||||||||||||||||||||||
| Interest income | $ | (37) | |||||||||||||||||||||||||||||||||||||||||||||
| Interest expense | 406 | ||||||||||||||||||||||||||||||||||||||||||||||
| Other, net | 62 | ||||||||||||||||||||||||||||||||||||||||||||||
| Income before Income Taxes | $ | 669 | |||||||||||||||||||||||||||||||||||||||||||||
| Beef | Pork | Chicken | Prepared Foods | International | Unallocated (Corporate) | Total | |||||||||||||||||||||||||||||||||||||||||
| Other segment information: | |||||||||||||||||||||||||||||||||||||||||||||||
| Depreciation | $ | 216 | $ | 63 | $ | 542 | $ | 252 | $ | 59 | $ | 35 | $ | 1,167 | |||||||||||||||||||||||||||||||||
| Additions to property, plant and equipment | 89 | 67 | 388 | 171 | 32 | 23 | 770 | ||||||||||||||||||||||||||||||||||||||||
| Total Assets | 3,028 | 1,607 | 11,995 | 14,578 | 1,702 | 2,196 | 35,106 |
| Twelve months ended September 27, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||
| Beef | Pork | Chicken | Prepared Foods | International | Intersegment | Total | |||||||||||||||||||||||||||||||||||||||||
| Sales(a) | $ | 21,623 | $ | 5,781 | $ | 16,837 | $ | 9,930 | $ | 2,291 | $ | (2,021) | $ | 54,441 | |||||||||||||||||||||||||||||||||
| Segment Cost of Sales | 22,117 | 5,884 | 14,502 | 8,321 | 1,995 | (2,021) | |||||||||||||||||||||||||||||||||||||||||
| Segment Selling, General and Administrative | 99 | 38 | 443 | 412 | 111 | — | |||||||||||||||||||||||||||||||||||||||||
| Facility fire-related costs (insurance proceeds) | — | — | — | — | (18) | — | |||||||||||||||||||||||||||||||||||||||||
| Restructuring and related charges | 48 | — | 9 | (26) | 14 | — | |||||||||||||||||||||||||||||||||||||||||
| Legal contingency accruals | — | — | — | — | 40 | — | |||||||||||||||||||||||||||||||||||||||||
| Plant closure and disposal charges | — | — | 23 | — | (6) | — | |||||||||||||||||||||||||||||||||||||||||
| Goodwill and intangible impairments | 343 | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
| Product recall | — | — | — | (25) | — | — | |||||||||||||||||||||||||||||||||||||||||
| Segment Operating Income (Loss) | $ | (984) | $ | (141) | $ | 1,860 | $ | 1,248 | $ | 155 | $ | — | $ | 2,138 | |||||||||||||||||||||||||||||||||
| Corporate expenses | (783) | ||||||||||||||||||||||||||||||||||||||||||||||
| Amortization(d) | (257) | ||||||||||||||||||||||||||||||||||||||||||||||
| Operating Income (Loss) | $ | 1,098 | |||||||||||||||||||||||||||||||||||||||||||||
| Other (Income) Expense: | |||||||||||||||||||||||||||||||||||||||||||||||
| Interest income | $ | (73) | |||||||||||||||||||||||||||||||||||||||||||||
| Interest expense | 449 | ||||||||||||||||||||||||||||||||||||||||||||||
| Other, net | (47) | ||||||||||||||||||||||||||||||||||||||||||||||
| Income before Income Taxes | $ | 769 | |||||||||||||||||||||||||||||||||||||||||||||
| Beef | Pork | Chicken | Prepared Foods | International | Unallocated (Corporate) | Total | |||||||||||||||||||||||||||||||||||||||||
| Other segment information: | |||||||||||||||||||||||||||||||||||||||||||||||
| Depreciation | $ | 167 | $ | 60 | $ | 533 | $ | 243 | $ | 62 | $ | 28 | $ | 1,093 | |||||||||||||||||||||||||||||||||
| Additions to property, plant and equipment | 156 | 66 | 510 | 155 | 50 | 41 | 978 | ||||||||||||||||||||||||||||||||||||||||
| Total Assets | 3,818 | 1,490 | 11,968 | 14,845 | 1,849 | 2,688 | 36,658 |
| Twelve months ended September 28, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||
| Beef | Pork | Chicken | Prepared Foods | International | Intersegment | Total | |||||||||||||||||||||||||||||||||||||||||
| Sales(a) | $ | 20,479 | $ | 5,903 | $ | 16,425 | $ | 9,851 | $ | 2,353 | $ | (1,702) | $ | 53,309 | |||||||||||||||||||||||||||||||||
| Segment Cost of Sales | 20,542 | 5,707 | 14,580 | 8,113 | 2,091 | (1,702) | |||||||||||||||||||||||||||||||||||||||||
| Segment Selling, General and Administrative | 94 | 33 | 425 | 490 | 148 | — | |||||||||||||||||||||||||||||||||||||||||
| Facility fire-related costs (insurance proceeds) | — | — | (70) | — | 86 | — | |||||||||||||||||||||||||||||||||||||||||
| Brand and product line discontinuations | — | — | 4 | 2 | — | — | |||||||||||||||||||||||||||||||||||||||||
| Restructuring and related charges | 3 | 1 | — | 22 | — | — | |||||||||||||||||||||||||||||||||||||||||
| Legal contingency accruals | 45 | 28 | 56 | — | — | — | |||||||||||||||||||||||||||||||||||||||||
| Plant closure and disposal charges | 41 | 108 | 33 | — | — | — | |||||||||||||||||||||||||||||||||||||||||
| Segment Operating Income (Loss) | $ | (246) | $ | 26 | $ | 1,397 | $ | 1,224 | $ | 28 | $ | — | $ | 2,429 | |||||||||||||||||||||||||||||||||
| Corporate expenses(c) | (791) | ||||||||||||||||||||||||||||||||||||||||||||||
| Amortization(d) | (229) | ||||||||||||||||||||||||||||||||||||||||||||||
| Operating Income (Loss) | $ | 1,409 | |||||||||||||||||||||||||||||||||||||||||||||
| Other (Income) Expense: | |||||||||||||||||||||||||||||||||||||||||||||||
| Interest income | $ | (89) | |||||||||||||||||||||||||||||||||||||||||||||
| Interest expense | 481 | ||||||||||||||||||||||||||||||||||||||||||||||
| Other, net | (75) | ||||||||||||||||||||||||||||||||||||||||||||||
| Income before Income Taxes | $ | 1,092 | |||||||||||||||||||||||||||||||||||||||||||||
| Beef | Pork | Chicken | Prepared Foods | International | Unallocated (Corporate) | Total | |||||||||||||||||||||||||||||||||||||||||
| Other segment information: | |||||||||||||||||||||||||||||||||||||||||||||||
| Depreciation | $ | 158 | $ | 123 | $ | 539 | $ | 233 | $ | 56 | $ | 50 | $ | 1,159 | |||||||||||||||||||||||||||||||||
| Additions to property, plant and equipment | 138 | 41 | 505 | 334 | 50 | 64 | 1,132 | ||||||||||||||||||||||||||||||||||||||||
| Total Assets | 3,608 | 1,531 | 11,917 | 15,010 | 1,951 | 3,083 | 37,100 |
(a) Fiscal 2026 included legal contingency accruals of $190 million, $70 million and $98 million in the Beef, Pork and Chicken segments, respectively. Sales attributable to the additional week were $385 million, $112 million, $343 million, $197 million and $48 million for the Beef, Pork, Chicken, Prepared Foods and International segments, respectively, partially offset by $36 million of intersegment sales eliminations. The impact of the additional week on Sales was calculated by dividing fourth quarter sales, excluding legal contingency accruals recognized as a reduction to Sales that were not impacted by the additional week, by 14 weeks. Fiscal 2025 included legal contingency accruals of $318 million and $380 million in the Beef and Pork segments, respectively, and $66 million related to a product recall in the Prepared Foods segment. Fiscal 2024 included a $45 million legal contingency accrual in the Pork segment.
(b) Other segment items consist of the impact of the additional week in fiscal 2026 on Segment Cost of Sales and Segment Selling, General and Administrative. Our CODM regularly reviews segment expenses on a comparative 52-week basis when assessing performance and allocating resources; accordingly, the impact of the additional week is presented separately from the significant segment expenses above. The impact was calculated by dividing the respective fourth quarter amounts, excluding items affecting comparability, by 14 weeks.
(c) Included $6 million of restructuring and related charges, $83 million of executive leadership transition charges and $15 million attributable to the additional week in fiscal year 2026. Included $5 million of restructuring and related charges for the fiscal year 2024.
(d) Included $4 million attributable to the additional week in fiscal year 2026. Included $23 million and $2 million of accelerated amortization related to brand and product line discontinuations for fiscal year 2025 and fiscal year 2024, respectively.
Our largest customer, Walmart Inc., accounted for 19.0%, 18.7% and 18.4% of consolidated sales in fiscal 2026, 2025 and 2024, respectively. Sales to Walmart Inc. were included in all of the segments. Any extended discontinuance of sales to this customer could, if not replaced, have a material impact on our operations.
The majority of our operations are domiciled in the United States. Approximately 95% of sales to external customers for each of fiscal 2026, 2025 and 2024 were sourced from the United States. At October 3, 2026 and September 27, 2025, long-lived assets, excluding goodwill, intangible assets, financial instruments and deferred tax assets, located in the United States were approximately $8.9 billion and $9.5 billion, respectively, and long-lived assets located in foreign locations were approximately $0.7 billion and $0.7 billion, respectively. Our foreign long-lived assets were located primarily in Brazil, China, New Zealand, Malaysia, the Middle East and Thailand.
We sell certain products in foreign markets, primarily Canada, Central America, China, the European Union, the United Kingdom, Japan, Mexico, Malaysia, the Middle East, the Philippines, Singapore, South Korea, Taiwan, Thailand and Vietnam. Our export sales from the United States totaled $4.8 billion, $4.8 billion and $5.2 billion for fiscal 2026, 2025 and 2024, respectively. Substantially all of our export sales are facilitated through unaffiliated brokers, marketing associations and foreign sales offices. Sales of products produced in a country other than the United States were less than 10% of consolidated sales for each of fiscal 2026, 2025 and 2024. The following tables further disaggregate our sales to customers by major distribution channels (in millions):
| Twelve months ended October 3, 2026 | |||||||||||||||||||||||||||||||||||||||||
| Retail(a) | Foodservice(b) | International(c) | Industrial and Other(d) | Total External Customers | Intersegment | Total | |||||||||||||||||||||||||||||||||||
| Beef | $ | 10,839 | $ | 5,837 | $ | 2,059 | $ | 2,369 | $ | 21,104 | $ | 558 | $ | 21,662 | |||||||||||||||||||||||||||
| Pork | 1,885 | 626 | 1,341 | 1,070 | 4,922 | 1,406 | 6,328 | ||||||||||||||||||||||||||||||||||
| Chicken | 7,452 | 6,747 | 1,081 | 2,191 | 17,471 | 93 | 17,564 | ||||||||||||||||||||||||||||||||||
| Prepared Foods | 6,131 | 3,832 | 260 | 272 | 10,495 | — | 10,495 | ||||||||||||||||||||||||||||||||||
| International | — | — | 2,427 | — | 2,427 | — | 2,427 | ||||||||||||||||||||||||||||||||||
| Intersegment | — | — | — | — | — | (2,057) | (2,057) | ||||||||||||||||||||||||||||||||||
| Total | $ | 26,307 | $ | 17,042 | $ | 7,168 | $ | 5,902 | $ | 56,419 | $ | — | $ | 56,419 |
| Twelve months ended September 27, 2025 | |||||||||||||||||||||||||||||||||||||||||
| Retail(a) | Foodservice(b) | International(c) | Industrial and Other(d) | Total External Customers | Intersegment | Total | |||||||||||||||||||||||||||||||||||
| Beef | $ | 10,920 | $ | 5,786 | $ | 2,249 | $ | 2,150 | $ | 21,105 | $ | 518 | $ | 21,623 | |||||||||||||||||||||||||||
| Pork | 1,880 | 548 | 1,186 | 767 | 4,381 | 1,400 | 5,781 | ||||||||||||||||||||||||||||||||||
| Chicken | 6,942 | 6,660 | 1,104 | 2,028 | 16,734 | 103 | 16,837 | ||||||||||||||||||||||||||||||||||
| Prepared Foods | 5,788 | 3,636 | 242 | 264 | 9,930 | — | 9,930 | ||||||||||||||||||||||||||||||||||
| International | — | — | 2,291 | — | 2,291 | — | 2,291 | ||||||||||||||||||||||||||||||||||
| Intersegment | — | — | — | — | — | (2,021) | (2,021) | ||||||||||||||||||||||||||||||||||
| Total | $ | 25,530 | $ | 16,630 | $ | 7,072 | $ | 5,209 | $ | 54,441 | $ | — | $ | 54,441 |
| Twelve months ended September 28, 2024 | |||||||||||||||||||||||||||||||||||||||||
| Retail(a) | Foodservice(b) | International(c) | Industrial and Other(d) | Total External Customers | Intersegment | Total | |||||||||||||||||||||||||||||||||||
| Beef | $ | 9,915 | $ | 5,215 | $ | 2,659 | $ | 2,245 | $ | 20,034 | $ | 445 | $ | 20,479 | |||||||||||||||||||||||||||
| Pork | 1,804 | 498 | 1,364 | 1,078 | 4,744 | 1,159 | 5,903 | ||||||||||||||||||||||||||||||||||
| Chicken | 6,994 | 6,432 | 957 | 1,944 | 16,327 | 98 | 16,425 | ||||||||||||||||||||||||||||||||||
| Prepared Foods | 5,794 | 3,629 | 225 | 203 | 9,851 | — | 9,851 | ||||||||||||||||||||||||||||||||||
| International | — | — | 2,353 | — | 2,353 | — | 2,353 | ||||||||||||||||||||||||||||||||||
| Intersegment | — | — | — | — | — | (1,702) | (1,702) | ||||||||||||||||||||||||||||||||||
| Total | $ | 24,507 | $ | 15,774 | $ | 7,558 | $ | 5,470 | $ | 53,309 | $ | — | $ | 53,309 |
(a) Includes external sales to consumer products and food retailers, such as grocery retailers, warehouse club stores and internet-based retailers.
(b) Includes external sales to foodservice distributors, restaurant operators, hotel chains and noncommercial foodservice establishments such as schools, convenience stores, healthcare facilities and the military.
(c) Includes external sales to international markets related to internationally produced products and export sales of domestically produced products.
(d) Includes external sales to industrial food processing companies that further process our product to sell to end consumers and any remaining sales not included in the Retail, Foodservice or International categories. For fiscal 2026, industrial and other included reductions of $190 million, $70 million and $98 million for the Beef, Pork and Chicken segments, respectively, due to the recognition of legal contingency accruals. For fiscal 2025, industrial and other included reductions of $318 million and $380 million for the Beef and Pork segments, respectively, due to the recognition of legal contingency accruals. For fiscal 2024, industrial and other included a reduction of $45 million in the Pork segment due to the recognition of a legal contingency accrual.
NOTE 18: SUPPLEMENTAL CASH FLOW INFORMATION
The following table summarizes cash payments for interest and income taxes, net of refunds, for fiscal years ended 2026, 2025 and 2024 (in millions):
| 2026 | 2025 | 2024 | |||||||||||||||
| Interest, net of amounts capitalized | $ | 437 | $ | 402 | $ | 460 | |||||||||||
| Income taxes, net of refunds | 377 | 331 | 227 |
Capital expenditures of $109 million, $168 million and $131 million were included in accounts payable at the end of fiscal 2026, 2025 and 2024, respectively, and were excluded from additions to property, plant and equipment in the Consolidated Statements of Cash Flows.
NOTE 19: TRANSACTIONS WITH RELATED PARTIES
We have related party leases for two wastewater facilities with an entity owned by the Donald J. Tyson Revocable Trust (for which Mr. John H. Tyson, Chairman of the Company, is a trustee), Berry Street Waste Water Treatment Plant, LP (90% of which is owned by the TLP) and the sisters of Mr. Tyson. As of October 3, 2026 and September 27, 2025, one lease was classified as a finance lease with a debt balance of $5 million, which was primarily recognized in Long-Term Debt in our Consolidated Balance Sheets. The other lease was classified as an operating lease with a lease liability of less than approximately $1 million as of October 3, 2026 and September 27, 2025, which was primarily recognized within Other Liabilities in our Consolidated Balance Sheets. Payments to lease the facilities totaled approximately $1 million in each of fiscal 2026, 2025 and 2024.
As of October 3, 2026, the TLP, of which John H. Tyson and director Barbara Tyson are general partners, owned 70 million shares, or 99.987% of our outstanding Class B stock and, along with the members of the Tyson family, owned 7.0 million shares of Class A stock, giving it control of approximately 72.40% of the total voting power of our outstanding voting stock.
In fiscal 2026, 2025 and 2024, the Company provided administrative services to the TLP, the beneficial owner of 70 million shares of Class B stock, and the TLP, through TLP Investment, L.P., reimbursed the Company $0.5 million in fiscal 2026, $0.4 million in fiscal 2025 and $0.2 million in fiscal 2024.
In fiscal 2025, the Company sold fourteen pieces of artwork from its offices to North Ark Bahamas, LLC, an entity owned by John H. Tyson, John R. Tyson and Olivia L. Tyson, for an aggregate price of $0.2 million.
In fiscal 2024, the Company purchased real estate located in Springdale, Arkansas, for $0.8 million from TBB Land Holdings LLC. TBB Land Holdings LLC is wholly owned by John H. Tyson.
NOTE 20: COMMITMENTS AND CONTINGENCIES
Commitments
We guarantee obligations of certain outside third parties, consisting primarily of grower loans, which are substantially collateralized by the underlying assets. The remaining terms of the underlying obligations extend for periods of up to 5 years, and the maximum potential amount of future payments as of October 3, 2026 was not significant. Material payments under these guarantees are not considered probable. At October 3, 2026 and September 27, 2025, no significant liabilities for guarantees were recorded.
We have cash flow assistance programs in which certain livestock suppliers participate. Under these programs, we pay an amount for livestock equivalent to the standard cost of raising the livestock during periods of low market sales prices. Amounts paid in excess of the market sales price are recorded as receivables and accrue interest. Participating suppliers are obligated to repay these amounts when market sales prices exceed the standard cost or upon termination of the agreement. Our maximum commitment under these programs is limited to either a set dollar amount or the fair value of each participating livestock supplier’s net tangible assets. The maximum potential obligation as of October 3, 2026 was approximately $140 million. At October 3, 2026 and September 27, 2025, we did not have significant net receivables outstanding under these programs.
When constructing new facilities or making major enhancements to existing facilities, we occasionally enter into incentive agreements with local government agencies to reduce certain state and local tax expenditures. Additionally, under certain agreements, we transfer the related assets to various local government entities and receive Industrial Revenue Bonds. We immediately lease the facilities from these entities and have an option to repurchase the facilities for a nominal amount upon tendering the Industrial Revenue Bonds to these entities at predetermined dates. The Industrial Revenue Bonds and associated lease obligations offset, and the underlying assets remain in property, plant and equipment. At October 3, 2026, amounts under these arrangements totaled $806 million.
Additionally, we enter into other purchase commitments, such as those for grains, livestock contracts and variable livestock grower commitments. Estimable commitments with a remaining term greater than one year as of October 3, 2026 were (in millions):
| Purchase Obligations | |||||
| 2027 | $ | 660 | |||
| 2028 | 517 | ||||
| 2029 | 416 | ||||
| 2030 | 377 | ||||
| 2031 | 278 | ||||
| 2032 and beyond | 3,206 | ||||
| Total | $ | 5,454 |
Contingencies
In the normal course of business, we are involved in various claims, lawsuits, investigations and legal proceedings, including those specifically identified below. Each quarter, we determine whether to accrue for loss contingencies based on our assessment of whether the potential loss is probable, reasonably possible or remote and, if probable, whether the loss is reasonably estimable. We record accruals in the Company’s consolidated financial statements for matters for which we conclude a loss is probable and reasonably estimable. The Company further determines whether a range of possible loss, if any, in excess of the recorded accrual is reasonably estimable. Regardless of the manner of resolution, the most significant changes in the status of a matter may occur over a short period, often following a lengthy period of little substantive activity. While these accruals reflect the Company’s best estimate of the probable loss for those matters as of the dates of those accruals, the recorded amounts may differ materially from the actual losses. Listed below are certain claims made against the Company for which the magnitude of the potential exposure could be material to the Company’s consolidated financial statements.
Broiler Antitrust Civil Litigation and Related Matters
Beginning in September 2016, a series of putative federal class action lawsuits styled In re Broiler Chicken Antitrust Litigation (the “Broiler Antitrust Civil Litigation”) were filed in the United States District Court for the Northern District of Illinois against us and certain of our poultry subsidiaries, as well as several other poultry processing companies and Agri Stats, Inc. (“Agri Stats”), an information service provider. As described below, the Company reached agreements to settle all outstanding claims brought against it by the putative classes, and the Court has granted final approval to these settlements.
Certain putative class members chose to opt out of the classes and pursue individual claims against the Company and other defendants in the United States District Court for the Northern District of Illinois. The operative complaints allege that beginning in January 2008, the defendants conspired and combined to fix, raise, maintain and stabilize the price of broiler chickens and that the defendants manipulated and artificially inflated the Georgia Dock price index. The plaintiffs further allege that the defendants concealed this conduct from the plaintiffs and the members of the putative classes. The plaintiffs seek treble damages, injunctive relief, pre- and post-judgment interest, costs and attorneys’ fees under the United States antitrust laws and various state unfair competition laws, consumer protection laws and unjust enrichment common laws.
The Court divided the case into two tracks. Plaintiffs electing to proceed in the first track (“Track One”) chose to forgo claims relating to the United States Department of Justice (“DOJ”) criminal investigation described below. Plaintiffs electing to proceed in the second track (“Track Two”) could pursue those claims but were required to wait until the completion of the Track One proceedings before doing so.
The first trial in this matter, which involved claims brought by the direct purchaser plaintiff class and certain direct-action plaintiffs, began on September 12, 2023 and concluded with a jury verdict in favor of the defendants on October 25, 2023. The Company did not participate in the first trial because it had previously settled all of the claims brought by the plaintiffs that participated in that trial. The second and third scheduled trials in this matter, which were to involve claims brought by the commercial and institutional indirect purchaser plaintiff class and the end-user consumer plaintiff class, respectively, were scheduled to begin in March 2024 and September 2024, respectively. Both trials were canceled because all claims brought by these classes were resolved before trial. This completed the Track One proceedings.
On February 11, 2025, the Court denied the defendants’ motion to dismiss the allegations brought by the Track Two plaintiffs. On March 7, 2025, the Court lifted the stay of discovery that had applied to the Track Two claims. Fact discovery in Track Two is now complete, and expert discovery is underway. The Court has entered a case schedule under which the first Track Two trial will begin in September 2027.
Settlements
On January 19, 2021, we announced that we had reached agreements to settle certain class claims related to the Broiler Antitrust Civil Litigation. Settlement terms were reached with the putative direct purchaser plaintiff class, the putative commercial and institutional indirect purchaser plaintiff class and the putative end-user consumer plaintiff class (collectively, the “Classes”). Under the terms of the settlements, we agreed to pay the Classes an aggregate amount of $221.5 million to settle all outstanding claims brought by the Classes. On June 29, 2021, December 20, 2021 and April 18, 2022, the Court granted final approval to the settlements with the direct purchaser plaintiff class, the end-user consumer plaintiff class and the commercial and institutional indirect purchaser plaintiff class, respectively. The foregoing settlements do not settle claims made by plaintiffs who have opted out of the Classes in the Broiler Antitrust Civil Litigation.
We are currently pursuing settlement discussions with the remaining opt-out plaintiffs regarding the remaining claims. While we do not admit any liability as part of the settlements, we believe that the settlements we have entered into were in the best interests of the Company and its shareholders because they avoided the uncertainty, risk, expense and distraction of protracted litigation.
Government Investigations
U.S. Department of Justice Antitrust Division. On June 21, 2019, the DOJ filed a motion to intervene and sought a limited stay of discovery in the Broiler Antitrust Civil Litigation, which the Court granted in part. Subsequently, we received a grand jury subpoena from the DOJ seeking additional documents and information related to the chicken industry. On June 2, 2020, a grand jury for the District of Colorado returned an indictment charging four individual executives employed by two other poultry processing companies with conspiracy to engage in bid-rigging in violation of federal antitrust laws. On June 10, 2020, we announced that we uncovered information in connection with the grand jury subpoena that we had previously self-reported to the DOJ and that we were cooperating with the DOJ as part of our application for leniency under the DOJ’s Corporate Leniency Program. Subsequently, the DOJ announced indictments against additional individuals, as well as other poultry processing companies, alleging a conspiracy to fix prices and rig bids for broiler chicken products from at least 2012 until at least early 2019. None of these indictments remain pending. In August 2021, the Company was granted conditional leniency by the DOJ for the matters we self-reported, which means that, provided the Company continues to cooperate with the DOJ, neither the Company nor any of our cooperating employees will face prosecution or criminal fines or penalties. We continue to cooperate with the DOJ in connection with the ongoing federal antitrust investigation.
State Attorney General Matters. The Offices of the Attorneys General in Washington, New Mexico and Alaska filed complaints against us and certain of our poultry subsidiaries, as well as several other poultry processing companies and Agri Stats, based on allegations similar to those asserted in the Broiler Antitrust Civil Litigation. These complaints alleged violations of state antitrust, unfair trade practice and unjust enrichment laws. We are cooperating with various state governmental agencies and officials, including the Offices of the Attorneys General of Florida and Louisiana, that are investigating or otherwise seeking information, testimony and/or documents regarding the conduct alleged in the Broiler Antitrust Civil Litigation and related matters. In October 2022, we reached an agreement to settle all claims with the Washington Attorney General, and the Court entered a consent decree on October 24, 2022. On February 16, 2024, the Company and the State of Alaska filed a stipulation and proposed consent decree reflecting a settlement of the claims against the Company asserted by the Office of the Attorney General of Alaska. The Court approved this settlement on April 24, 2024. On April 19, 2024, the Company and the State of New Mexico filed a proposed consent judgment reflecting a settlement of the claims against the Company asserted by the Office of the Attorney General of New Mexico. The Court approved this settlement on July 23, 2024. While the Company believes it has meritorious defenses to the claims that have been made, we believe that these settlements were in the best interests of the Company and its shareholders because they avoided the uncertainty, risk, expense and distraction of protracted litigation.
At October 3, 2026 and September 27, 2025, the legal contingency accrual for claims related to the Broiler Antitrust Civil Litigation matters described above was $109 million and $64 million, respectively. During fiscal 2026, the Company increased the contingency accrual for claims related to these matters by $98 million and did not record any additional contingency accruals during fiscal 2025 or fiscal 2024. Additionally, the Company reduced its recorded legal contingency accrual for payments related to these matters by $53 million, $22 million and $98 million for settlements with other plaintiffs outside of the Classes during fiscal 2026, fiscal 2025 and fiscal 2024, respectively. The Company does not believe that a range of possible loss, if any, in excess of the recorded accrual is reasonably estimable at this time. However, if the facts and circumstances related to these matters or assumptions based on present conditions used to determine our estimated liability were to change significantly, we may be exposed to additional material losses.
Pork Antitrust Civil Litigation
Beginning June 18, 2018, a series of putative class action complaints were filed against us and certain of our pork subsidiaries, as well as several other pork processing companies, in the United States District Court for the District of Minnesota styled In re Pork Antitrust Litigation (the “Pork Antitrust Civil Litigation”). The plaintiffs allege, among other things, that beginning in January 2009, the defendants conspired and combined to fix, raise, maintain and stabilize the price of pork and pork products in violation of federal antitrust laws. The complaints on behalf of the putative classes of indirect purchasers also include causes of action under various state unfair competition laws, consumer protection laws and unjust enrichment common laws. The plaintiffs seek treble damages, injunctive relief, pre- and post-judgment interest, costs and attorneys’ fees on behalf of the putative classes. Since the original filing, certain putative class members have opted out of the matter and are pursuing individual direct actions asserting similar claims, and others may do so in the future.
The Offices of the Attorney General in New Mexico and Alaska filed complaints against us and certain of our pork subsidiaries, as well as several other pork processing companies and Agri Stats. The complaints are based on allegations similar to those asserted in the Pork Antitrust Civil Litigation and allege violations of state antitrust, unfair trade practice and unjust enrichment laws arising from alleged conspiracies to exchange information and manipulate the supply of pork. On October 18, 2024, we reached a settlement with the State of Alaska to resolve all claims made against the Company for an immaterial amount. The court approved the settlement on January 7, 2025. On May 9, 2025, the Company reached an agreement in principle with the State of New Mexico to resolve all claims made against the Company for an immaterial amount. The court approved the settlement on August 11, 2025. While the Company believes it has meritorious defenses to the claims that have been made, we believe that the settlements were in the best interests of the Company and its shareholders because they avoided the uncertainty, risk, expense and distraction of protracted litigation.
In the third quarter of fiscal 2024, we filed and joined motions for summary judgment. On March 31, 2025, the Court denied those summary judgment motions as to the claims against the Company. The Company anticipates multiple trials in this matter in various federal districts. The first of these trials was scheduled to begin in May 2026 and involved civil claims brought by the DOJ and several state attorneys general against Agri Stats. The parties reached settlements and therefore the trial was canceled. The next trial was scheduled to begin in September 2026, but was canceled following settlements by the parties that would have participated in the trial. The Court provided an opportunity for voluntary mediation among the remaining parties after which it will suggest that the Judicial Panel on Multidistrict Litigation remand claims filed in other jurisdictions to the jurisdictions in which those claims were filed.
While we believe we have valid and meritorious defenses to the claims that have been made in the Pork Antitrust Civil Litigation, we have entered into and continue to explore settlements with plaintiff classes and opt-out plaintiffs in the Pork Antitrust Civil Litigation and related matters to avoid the uncertainty, risk, expense and distraction of protracted litigation. On April 11, 2025, the Company reached an agreement in principle with the direct purchaser plaintiff class to settle their claims in this matter for an aggregate of $50 million. The Court granted preliminary approval of the settlement on April 28, 2025, and granted final approval on August 13, 2025. On September 25, 2025, the Company reached an agreement with the consumer indirect purchaser plaintiff class to settle their claims in this matter for an aggregate of $85 million. On November 7, 2025, the Court granted preliminary approval of the settlement. On December 31, 2025, the Company executed an agreement with the commercial and institutional indirect purchaser plaintiff class to settle their claims in this matter for an aggregate of $48 million. The Court granted preliminary approval of the settlement on April 24, 2026, and granted final approval on October 8, 2026.
At October 3, 2026 and September 27, 2025, the legal contingency accrual for claims related to the Pork Antitrust Civil Litigation matter described above was $93 million and $268 million, respectively. The Company increased the contingency accrual for claims related to this matter by $70 million, $380 million and $45 million during fiscal 2026, 2025 and 2024, respectively. Additionally, the Company reduced its recorded legal contingency accrual for payments related to this matter by $85 million for the consumer indirect purchaser plaintiff class settlement, $48 million for the commercial and institutional indirect purchaser plaintiff class settlement and $112 million for settlements with opt-out and other direct-action plaintiffs during fiscal 2026, and by $50 million for the direct purchaser plaintiff class settlement and $107 million for settlements with opt-out and other direct-action plaintiffs during fiscal 2025. The Company does not believe that a range of possible loss, if any, in excess of the recorded accrual is reasonably estimable at this time. However, if the facts and circumstances related to this matter or the assumptions based on present conditions used to determine our estimated liability were to change significantly, we may be exposed to additional material losses.
Beef Antitrust Civil Litigation and Related Matters
Beginning on April 23, 2019, a series of class action complaints were filed against us and our beef and pork subsidiary, Tyson Fresh Meats, Inc. (“Tyson Fresh Meats”), as well as other beef packer defendants, in various federal district courts, including the United States District Court for the Northern District of Illinois, the United States District Court for the District of Minnesota and the United States District Court for the District of Kansas, by putative classes of direct purchasers, cattle ranchers, indirect purchasers and indirect cattle producers (the “Beef Antitrust Civil Litigation”). The putative classes in these cases alleged that the defendants engaged in one or more conspiracies beginning in roughly January 2015 with the aim of reducing fed cattle prices, manipulating the price of live cattle futures and options traded on the Chicago Mercantile Exchange, artificially increasing the cost of beef and reducing the price of cows, cattle, calves, steers or heifers. The putative classes alleged that this conduct violated federal antitrust laws, the Grain Inspection, Packers and Stockyards Act of 1921, the Commodity Exchange Act and various state unfair competition, consumer protection and unjust enrichment laws. Their complaints sought, among other things, treble monetary damages, punitive damages, restitution and pre- and post-judgment interest, as well as declaratory and injunctive relief. Since the original filing, certain putative class members have opted out of the matter and are proceeding with individual direct actions making similar claims, and others may do so in the future. These cases have been transferred to the United States District Court for the District of Minnesota for pretrial purposes. The fact discovery phase ended in early April 2025. The putative classes filed motions for class certification on September 25, 2024.
On September 29, 2025, the Company reached an agreement with the consumer indirect purchaser plaintiff class to settle their claims in this matter for an aggregate of $55 million. The Company paid the settlement on November 26, 2025, and the Court granted preliminary approval of the settlement on December 10, 2025, and final approval on May 27, 2026. On December 12, 2025, the Company reached an agreement in principle with the direct purchaser plaintiff class to settle their claims in this matter for an aggregate of $80 million plus $2.5 million in administrative expenses. The Company paid the settlement on January 7, 2026, and the Court granted preliminary approval of this settlement on May 14, 2026, and final approval on November 12, 2026. Also on December 12, 2025, the Company reached an agreement in principle with the commercial and institutional indirect purchaser plaintiff class to settle their claims in this matter for an aggregate of $47 million. The Court granted preliminary approval to this settlement on May 6, 2026, the Company paid this settlement on June 2, 2026, and the Court granted final approval to this settlement on October 8, 2026.
On July 16, 2026, the United States District Court for the District of Minnesota issued an order granting certain motions for class certification and denying others. Specifically, the Court granted certification to a class of upstream cattle sellers, referred to as the fed cattle class, and three downstream classes of beef buyers consisting of the direct purchaser class, the commercial and institutional indirect purchaser class and the consumer indirect purchaser class. It denied certification to two proposed upstream classes known as the feeder cattle class and the exchange class. The defendants litigating against the fed cattle class then sought, and received, permission for an interlocutory appeal from the United States Court of Appeals for the Eighth Circuit. Briefing in the appeal is underway. Additionally, following the denial of certification of the feeder cattle class, certain plaintiffs who claim to have been part of the putative feeder cattle class have brought direct actions against the Company and the other defendants. The defendants have moved to dismiss these claims, and their motion remains pending.
On February 18, 2022, a putative class action was commenced against us, Tyson Fresh Meats and other beef packer defendants in the Supreme Court of British Columbia styled Bui v. Cargill, Incorporated et al. The putative class is comprised of direct and indirect beef purchasers in Canada between January 1, 2015 and the present, and alleges that the defendants conspired to fix, maintain, increase or control the price of beef, as well as to fix, maintain, control, prevent or lessen the production or supply of beef. The complaint alleges a violation of the Competition Act, civil conspiracy, unjust enrichment and a violation of the Civil Code of Québec. It seeks declarations regarding the alleged conspiracy, general damages, aggravated, exemplary and punitive damages, injunctive relief, costs and interest. On March 24, 2022, a putative class action was commenced against the same defendants in the Superior Court of Québec styled De Bellefeuille v. Cargill, Incorporated et al., raising substantially similar allegations and seeking compensatory damages, costs of investigation and interest.
While we believe we have valid and meritorious defenses to the claims that have been made in the Beef Antitrust Civil Litigation and related matters, we have entered into and continue to explore opportunities to reach settlements if doing so would be in the best interest of the Company, as settlement could avoid the uncertainty, risk, expense and distraction of protracted litigation.
We have received civil investigative demands (“CIDs”) from the DOJ’s Civil Antitrust Division. The CIDs request information related to the Company’s beef business. We continue to cooperate with the DOJ with respect to the CIDs.
At October 3, 2026 and September 27, 2025, the legal contingency accrual for claims related to the Beef Antitrust Civil Litigation matter described above was $167 million and $318 million, respectively. The Company increased the contingency accrual for claims related to this matter by $190 million and $318 million in fiscal 2026 and fiscal 2025, respectively. Additionally, the Company reduced its recorded legal contingency accrual for payments related to this matter by $83 million for the direct purchaser plaintiff class settlement, $55 million for the consumer indirect purchaser plaintiff class settlement, $47 million for the commercial and institutional indirect purchaser plaintiff class settlement and $156 million for settlements with opt-out and other direct-action plaintiffs during fiscal 2026. The Company does not believe that a range of possible loss, if any, in excess of the recorded accrual is reasonably estimable at this time. However, if the facts and circumstances related to the matter or the assumptions based on present conditions used to determine our estimated liability were to change significantly, we may be exposed to additional material losses.
Wage Rate Litigation and Related Matters
Poultry. On August 30, 2019, a putative class of non-supervisory production and maintenance employees at chicken processing plants in the continental United States filed class action complaints against us and certain of our subsidiaries, as well as several other poultry processing companies, in the United States District Court for the District of Maryland. The plaintiffs allege that the defendants directly and through a wage survey and benchmarking service exchanged information regarding labor rates in an effort to depress and fix the rates of wages for non-supervisory production and maintenance workers in violation of federal antitrust laws. Additional lawsuits making similar allegations were consolidated, including an amended consolidated complaint containing additional allegations concerning turkey processing plants and naming additional defendants. Following mediation, on June 14, 2024, the Company reached an agreement in principle with the putative class plaintiffs to settle all claims in the case for an aggregate amount of $115.5 million. On February 11, 2025, the Court entered an order granting preliminary approval of the settlement, and on June 5, 2025, the Court entered an order granting final approval of the settlement. While we believe we had valid and meritorious defenses against the allegations, we also believed that the proposed settlement was in the best interests of the Company and its shareholders because it avoided the uncertainty, risk, expense and distraction of protracted litigation. During fiscal 2025, the accrued settlement amount was paid following preliminary court approval, and accordingly, there are no remaining accruals related to the Poultry wage rate litigation matter described above.
In December 2025 and January 2026, three groups, comprising fewer than 300 individuals in the aggregate, who had opted out of the Poultry wage rate litigation class filed complaints against the Company and other Poultry wage rate litigation defendants in the Circuit Courts of Barbour County and Bullock County, Alabama. The complaints repeated the essential factual allegations from the Poultry wage rate litigation but asserted solely state-law claims and were settled for an immaterial amount.
The DOJ’s Antitrust Division has opened a civil investigation into human resources at several poultry companies. We are cooperating with the investigation. The Company has not recorded any liability for this matter as it does not believe a loss is probable, nor does it believe that a range of possible loss, if any, is reasonably estimable at this time.
Fresh Meats. On November 11, 2022, a putative class of employees at beef-processing and pork-processing plants in the continental United States filed a class action complaint against us and certain of our subsidiaries, as well as several other beef-processing and pork-processing companies, in the United States District Court for the District of Colorado. The plaintiffs allege that the defendants directly and through a wage survey and benchmarking service exchanged information regarding labor rates in an effort to depress and fix the rates of wages for employees in violation of federal antitrust laws.
On December 22, 2023, after mediation between the parties, the Company reached an agreement in principle with the putative class plaintiffs to settle their claims against the Company. We believed that the proposed settlement was in the best interests of the Company and its shareholders because it avoided the uncertainty, risk, expense and distraction of protracted litigation. Under the terms of the settlement, the Company agreed to pay the putative class an aggregate amount of $72.5 million to completely resolve all claims made against the Company in this matter. The Court preliminarily approved the settlement on January 15, 2025, and the settlement was paid during fiscal 2025. On November 13, 2026, the Court granted final approval of this settlement.
Other Matters
Our subsidiary, The Hillshire Brands Company (formerly named Sara Lee Corporation), is a party to a consolidation of cases filed by individual complainants with the Republic of the Philippines, Department of Labor and Employment and the National Labor Relations Commission (“NLRC”) from 1998 through July 1999. The complaint was filed against Aris Philippines, Inc., Sara Lee Corporation, Sara Lee Philippines, Inc., Fashion Accessories Philippines, Inc. and Attorney Cesar C. Cruz (collectively, the “respondents”). The complaint alleges, among other things, that the respondents engaged in unfair labor practices in connection with the termination of manufacturing operations in the Philippines in 1995 by Aris Philippines, Inc., a former subsidiary of The Hillshire Brands Company. In late 2004, a labor arbiter ruled against the respondents and awarded the complainants approximately $55 million in damages and fees. From 2004 through 2014, the parties filed numerous appeals, motions for reconsideration and petitions for review, certain of which remained outstanding for several years. On December 15, 2016, we learned that the NLRC rendered its decision on November 29, 2016, regarding the respondents’ appeals from the labor arbiter’s 2004 ruling in favor of the complainants. The NLRC increased the award for 4,922 of the total 5,984 complainants to approximately $237 million. However, the NLRC approved a prior settlement reached with the group comprising approximately 18% of the class of 5,984 complainants, pursuant to which The Hillshire Brands Company agreed to pay each settling complainant approximately $1,085. The parties filed numerous appeals, motions for reconsideration and petitions for review related to the NLRC award and settlement payment. The Court of Appeals of the Philippines subsequently vacated the NLRC’s award on April 12, 2018. Complainants filed motions for reconsideration with the Court of Appeals, which were denied. Complainants have since filed petitions for writs of certiorari with the Supreme Court of the Philippines, which have been accepted. The Company continues to maintain an immaterial accrual for estimated probable losses related to this matter in the Company’s consolidated financial statements. The Company does not believe that a range of possible loss, if any, in excess of the recorded accrual is reasonably estimable at this time.
Various claims have been asserted against the Company, its subsidiaries and its officers and agents by, and on behalf of, team members who claim to have contracted COVID-19 in our facilities. In the fourth quarter of fiscal 2026, the Company recorded an accrual of $7 million for certain of these claims. The Company does not believe that a range of possible loss, if any, in excess of the recorded accrual is reasonably estimable at this time. The Company believes it has valid and meritorious defenses to the remaining claims.
For a tax-related matter involving the Company, refer to Part II, Item 8, Notes to Consolidated Financial Statements, Note 10: Income Taxes.
Report of Independent Registered Public Accounting Firm
To the Board of Directors and Shareholders of Tyson Foods, Inc.
Opinions on the Financial Statements and Internal Control over Financial Reporting
We have audited the accompanying consolidated balance sheets of Tyson Foods, Inc. and its subsidiaries (the "Company") as of October 3, 2026 and September 27, 2025, and the related consolidated statements of income, of comprehensive income, of shareholders' equity and of cash flows for each of the three years in the period ended October 3, 2026, including the related notes and schedule of valuation and qualifying accounts for each of the three years in the period ended October 3, 2026 appearing under Item 15 (collectively referred to as the "consolidated financial statements"). We also have audited the Company's internal control over financial reporting as of October 3, 2026, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of October 3, 2026 and September 27, 2025, and the results of its operations and its cash flows for each of the three years in the period ended October 3, 2026 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of October 3, 2026, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.
Basis for Opinions
The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management’s Annual Report on Internal Control Over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on the Company’s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.
Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.
Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Critical Audit Matters
The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
Goodwill Impairment Assessment – Prepared Foods Reporting Unit
As described in Note 1 and Note 5 to the consolidated financial statements, the Company’s goodwill balance was $9,469 million as of October 3, 2026, and the goodwill associated with the Prepared Foods reporting unit was $5,891 million. Goodwill is reviewed for impairment at least annually as of the first day of the fourth quarter, or more frequently if impairment indicators arise. If it is determined, based on qualitative factors, the fair value of the reporting unit may more likely than not be less than the carrying value, a quantitative impairment test would be required. Additionally, management can elect to forgo the qualitative assessment and perform the quantitative test. For fiscal 2026, management performed the annual goodwill impairment assessment as of the first day of the fourth quarter and elected to perform quantitative assessments for all material reporting units. Management estimates the fair value of reporting units considering the use of various valuation techniques, with the primary technique being an income approach (discounted cash flow method) and another technique being a market approach (guideline public company method). Management includes assumptions about sales growth, operating margins, discount rates, and valuation multiples which consider budgets, business plans, economic projections, anticipated future cash flows and marketplace data. Assumptions are also made for varying perpetual growth rates for periods beyond the long-term business plan period.
The principal considerations for our determination that performing procedures relating to the goodwill impairment assessment of the Prepared Foods reporting unit is a critical audit matter are (i) the significant judgment by management when developing the fair value estimate of the Prepared Foods reporting unit; (ii) a high degree of auditor judgment, subjectivity, and effort in performing procedures and evaluating management’s significant assumptions related to the sales growth, perpetual growth rate, operating margins, and discount rate used in the income approach and the valuation multiples used in the market approach; and (iii) the audit effort involved the use of professionals with specialized skill and knowledge.
Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to management’s goodwill impairment assessment, including controls over the valuation of the Prepared Foods reporting unit. These procedures also included, among others (i) testing management’s process for developing the fair value estimate of the Prepared Foods reporting unit; (ii) evaluating the appropriateness of the income and market approaches used by management; (iii) testing the completeness and accuracy of certain data used in the income and market approaches; and (iv) evaluating the reasonableness of management’s significant assumptions related to sales growth, perpetual growth rate, operating margins, and discount rate used in the income approach and valuation multiples used in the market approach. Evaluating management’s assumptions related to sales growth and operating margins involved considering (i) the current and past performance of the Prepared Foods reporting unit; (ii) the consistency with external market and industry data; and (iii) whether the assumptions were consistent with evidence obtained in other areas of the audit. Professionals with specialized skill and knowledge were used to assist in evaluating (i) the appropriateness of the income and market approaches and (ii) the reasonableness of the assumptions related to perpetual growth rate, discount rate, and valuation multiples.
/s/ PricewaterhouseCoopers LLP
Springdale, Arkansas
November 16, 2026
We have served as the Company’s auditor since 2009.
Previous: Item 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK · Next: Item 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE